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ABSTRACT 
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ABSTRACT 
Various dermatological disorders, such as formation of black pigmented patches on the surface 
of the skin arise from the over-activity of tyrosinase enzyme’s degenerative action. This enzyme 
is further implicated in the involvement of melanin in malignant melanoma, the most life-
threatening skin tumors. Although, synthetic products were found effective to combat this 
menace, nevertheless, overtime detrimental effect on human skin is a challenge. Investigation of 
natural tyrosinase inhibitors from methanol extracts of medicinal plants of Lamiaceae family 
using L-tyrosine as substrate on three different complementary assays (TLC bio-autography, 
spectrophotometry and cyclic voltammetry) was carried out accordingly. 
The result indicated Salvia chamelaeagnea, Salvia dolomitica, Plectranthus ecklonii, 
Plectranthus namaensis, and Plectranthus zuluensis, with significant zone of inhibition against 
tyrosinase on TLC bio-autography, spectrophotometry result showed that extracts of 
Plectranthus ecklonii (IC50 = 21.58 𝜇g/mL), Plectranthus zuluensis (IC50 = 23.99 𝜇g/mL), 
Plectranthus madagascariensis (IC50  = 23.99  𝜇g/mL) and Salvia lanceolata (IC50 = 28.83) 
demonstrated good anti-tyrosinase activity when compared with kojic acid (IC50 = 3.607 μg/mL). 
On the other hand, cyclic voltammetry are in consonant with above results thereby supported the 
nomination of some of the extracts as strong anti-tyrosinase agents. 
Salvia chamelaeagnea showed strong activity in cyclic voltammetry and clear zone of inhibition 
on TLC bioautography, these reasons gave us justification for further chemical study to isolate 
the bioactive constituents. 
Phytochemical investigation of the bioactive extract of Salvia chamelaeagnea using different 
chromatographic methods including column chromatographic and semi preparative HPLC 
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afforded six (6) known compounds viz carsonol (C1), carnosic acid (C2), 7- ethoxylrosmanol 
(C3), ursolic acid (C4), rosmanol (C5) and ladanein (C6). Their chemical structures were 
elucidated by analyses of spectroscopic (1H and 13C NMR) data as well as correlations with 
existing literature. The methanolic extract of S. chamelaeagnea (SC) showed moderate anti-
tyrosinase (IC50 = 267.4 µg/mL) activity, total antioxidant capacities measured as: Oxygen 
radicals absorbance capacity (ORAC; 14970 ± 5.16 µM TE/g), ferric-ion reducing antioxidant 
power (FRAP; 9869.43 ± 7.87 µM AAE/g) and trolox equivalent absorbance capacity (TEAC; 
13706.5 ± 0.95 µM TE/g). Excellent total antioxidant capacities were demonstrated by C1 and 
C5 respectively as FRAP (9338.92 ± 1.72; 8622.73 ± 1.92) µM AAE/g; TEAC (16505 ± 0.86; 
10641.5 ± 0.52) µM TE/g; ORAC (14550.5 ± 3.65; 14633.90 ± 3.84) µM TE/g and including the 
inhibition of Fe2+ -induced lipid peroxidation (IC50 = 32.5; 30.25) µg/mL. All the compounds 
except C4 are electro-active with well-defined oxidation-reduction peaks while C1 demonstrated 
the highest tyrosinase inhibitory activity by strongly decreased the inhibition current with time 
using cyclic voltammetry method.  
The isolated compounds especially C1, C2 and C5 are well known to combat with ageing 
problems and documented for their powerful activity against oxidative stress and alzheimer’s 
diseases, which are ageing related symptoms. The isolation of such bioactive compounds 
indicated the synergetic effect of the results of the three methods used in this thesis.  
This is the first report on the evaluation of both anti-tyrosinase and total antioxidant capacities of 
the isolated compounds from S. chamelaeagnea. The findings therefore can be used as 
background information for exploitation of skin depigmentation and antioxidant agents from 
natural source.  
Keywords : Lamiaceae; tyrosinase inhibitor; cyclic voltammetry; TLC bioautography;  
         medicinal plants; cosmetics; antioxidant; S. chamelaeagnea. 
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CHAPTER 1: INTRODUCTION 
 
1 
 
CHAPTER 1: INTRODUCTION 
1.1 General overview of the use of plants as source of medicines 
Plants have been used as a source of medicine since time immemorial for the purpose of curing 
numerous human afflictions (Fernnell, et al., 2004). The practice of using herbal medicine at 
early stage was primitively considered either an option for the less privileged or low-income 
earners (Rates, 2001). The use of folk medicine in developing countries has been a common 
practice and people have been able to treat ailments using plants within their respective locality 
in the mode of decoction and infusion (Rojas, et al., 2006). It has been estimated that up to 80 % 
of the population living in Africa uses traditional medicine as part of their primary healthcare 
system (Ekor, 2014). The use of traditional herbal remedies plays a vital role in South Africa, 
and forms the backbone of rural communities (Coopoosamy & Naidoo, 2013). Up to 60 % of the 
populations of the rural area in South Africa consult an approximation of 200,000 traditional 
healers. This huge turnout was ascribed to affordability, accessibility and most importantly 
freedom of expression of personal health status unlike orthodox medicines (Taylor, et al., 2001). 
Report shown that out of 30,000 species of higher plants present in South Africa, 10 % of these 
species have been found useful in traditional medicine around the country to treat different kind 
of disease such as cough, diarrhea, headaches, heart related problems, inflammation and 
prevention of abortion (Thring & Weitz, 2006). From the aforementioned, the beneficial usage of 
traditional medicine is receiving global icon of recognition compared to the synthetic drugs due 
to environmental friendly nature of the former (Iniaghe, et al., 2010). 
Medicinal plants contain a wide range of substances that can promote health and alleviate disease 
burden (Prajapati, et al., 2011). They have curative properties due to the presence of numerous 
bioactive constituents termed secondary metabolites (Karthikeyan & Balasubramanian, 2014). 
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These secondary metabolites range from terpenoids, phenolics, flavonoids, tannins and alkaloids 
which are of more beneficial effect to human than the plant itself (Shaukat, et al., 2013). 
1.2 Natural products as source of drugs 
Drugs derived from plants represent one of the most important sources of new and safe 
therapeutic agents. Many medicinal plants contain bioactive compounds that serve as precursors 
to synthesized drugs (Karthikeyan & Balasubramanian, 2014). Drugs derived from natural 
products have assumed greater value in recent days, due to the tremendous potential they offer in 
the formulation of new drugs, which may protect humankind against many diseases (Balunas & 
Kinghorn, 2005; Khalid, et al., 2013). It is estimated that 25-50 % of modern drugs are derived 
from plant origin with an approximation of 50 % of new drugs introduced in this time being has 
a natural product origin (Kingston, 2011). In Germany, 50 % of phytomedicinal products were 
sold based on the medical prescription (Rates, 2001; Bussmann, et al., 2010). Further evidence of 
the importance of natural products is provided by the fact that almost half of the world’s 25 best-
selling pharmaceuticals in 1991 were either natural products or their analogues (Ashour, et al., 
2013). Nowadays, plant derived drugs are predominantly important to the world population 
because of their safety profile (Vinha, et al., 2012; Nag, et al., 2013). 
1.3 Cosmeceutical exploration of African medicinal plants 
Traditional herbal medicines provide a very interesting source of potential new drugs and skin-
care products (Kiken & Cohen, 2002). There are innumerable South African plants that have 
wide application in cosmetic industry as additives to shampoo, shaving, skin care creams, skin 
disorders, treatment of burns and skin depigmenting agents (Lall & Kishore, 2014).  
Egyptians were the first since the ancient time to use herbal medicine such as the whipped 
ostrich eggs, olive oil, and resin mixed with milk for treating various skin ailments. Another 
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notable trend in the history of African medicinal plants is the usage of Eclipta prostrate 
commonly known as false daisy in Egypt as the fresh juice of the plant and applied directly to the 
scalp, and it is people’s believed to blacken the hair and beard (Lall & Kishore, 2014). 
In Rwanda, the purpose of lightening the skin using plants is a common practice, especially 
during the major ceremonies such as marriage. The leaves of numerous herbal plants have been 
used by Rwandese to treat skin disease, hyperpigmentation, leprosy, eczema and skin mycosis 
(Kamagaju, et al., 2013).   
The leaves of the plant species of Combretaceae (Anogeissus leiocarpus, Anogeissus schimperi 
and Conocarpus leiocarpus) are used in Nigeria in the treatment of skin diseases. Plumbago 
zeylanica (Plumbaginaceae), Artemisia absinthium (Asteraceae), Artemisia herba-alba 
(Asteraceae) are extremely popular throughout Africa and Asia as a remedy for parasitic skin 
diseases, especially leprosy, scabies, acne vulgaris, sores and leg ulcers (Dweck, 1996). Other 
medicinal plants with significant recognition as anti hyperpigmenting agents are Aloe species 
(Xanthorrhoeaceae), Cassipourea malosana (Rhizophoraceae), Sideroxylon inerme (Sapotaceae) 
(Van Wyk & Gericke, 2000; Momtaz, et al., 2008). 
There are numerous popular South African plants such as Aloe ferox Mill (Bitter Aloe: 
Xanthorrhoeaceae), Aspalathus linearis (Rooibos: Fabaceae), Calodendrum capense L.f. Thunb. 
(Cape Chestnut: Rutaceae), Cyclopia intermedia E. Mey (Honeybush: Fabaceae), Sideroxylon 
inerme L. (White milkwood: Sapotaceae) and Salvia stenophylla Burch. Ex Benth (Blue 
mountain sage: Lamiaceae) which are frequently used in various skin creams for slowing down 
aging process and other skin related ailments (Lall & Kishore, 2014). 
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1.4 Historical perspective of skin pigmentation 
Skin is the largest organ of the human body, accounting for about 15 % of the total adult body 
weight (Kanitakis, 2002). It serves as an important environmental interface that provides a 
protective envelope which is crucial for homeostasis (Chompo, et al., 2012). The structure of the 
skin is mainly made of two layers (Fig 1.1). The outer layer also called the epidermis, 
characterizing mainly of keratinocytes responsible for protecting the body against environmental 
damage, while the inner part, known as the dermis constitutes connective tissue and structural 
components such as collagen (responsible for skin firmness), elastic fibers (responsible for skin 
elasticity), and extracellular matrix (ECM) also known as structural components (Sparavigna, et 
al., 2013). However, human skin is exposed to the ultra violet (UV) radiation which on prolong 
exposure cause excessive accumulation of free radicals and other form of reactive oxygen 
species (ROS) including hydroxyl and peroxyl radicals, and hydrogen peroxide, which are 
primarily generated in the body as a result of physiological and biochemical processes (Aiyegoro 
& Okoh, 2010). Other notable ways of accumulating ROS in the body, is through continuous 
contact with the series of environmental cues such as UV radiation, human activities and 
lifestyles (Fearon & Faux, 2009; Chompo, et al., 2012). The free radical accumulation, when in 
excess in the body, can cause oxidative damage to some important macromolecules such as 
proteins, lipids and deoxyribonucleic acid (DNA), which eventually lead to many chronic 
diseases such as cancer, early aging, atherosclerosis, neurodegenerative disorders (Fig 1.2) (Niki, 
et al., 2005; Makrantonaki, et al., 2007), and other degenerative diseases in humans (Aiyegoro & 
Okoh, 2010). Other significant pathological implications of ROS in the body is the activation of 
skin enzyme’s degenerative actions, resulting in early or premature skin aging processes such as 
skin pigmentation (Corstjens, et al., 2007; Ndlovu, et al., 2013), sagging and wrinkle formation 
(Porcheron, et al., 2014). UV- exposed human skin may be an accessible model system in which 
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to characterize the role of oxidative damage in both internal and external tissue, given the 
compelling evidence for the role of ROS as mediators of photoaging (Watson, et al., 2014). 
 
* Source: www.leadinginstanteyelift.com 
Figure 1.1: Damage caused by UV to the structural elements of the skin  
 
 
*Source: www.healthyfellow.com 
Figure 1.2: Effects of UV radiation on human skin 
 
The occurrence of pigmented patches as shown in Figure 1.3 resulting from the accumulation of 
abnormal amount of melanin in different specific parts of the skin is referred to as skin 
pigmentation (Chompo, et al., 2012). This undesirable situation is caused by prolong exposure of 
human skin to the UV radiation, which resulted into over accumulation of free radicals in the 
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body (Wangthong, et al., 2007). The presence of excess of free radicals in the human body 
stimulated the activation of tyrosinase enzyme, which caused over-activity of the enzyme, 
thereby resulting into skin hyperpigmentation (Mapunya & Nikolova, 2012). 
 
Source: http://monsterblog.com.my 
Figure 1.3: Effect of skin pigmentation  
 
1.5 Oxidative Stress 
The formation of free radicals in human body is a continuous process which occurred through 
evolution after prolong exposure to UV radiations. Free radicals play vital roles in both inter and 
intracellular signaling (Munné-Bosch & Alegre, 2003), controlling vascular tone, defense against 
microorganisms, cell generation-degeneration, and basal regulation of homeostasis (Basu, 2010). 
However, when in excess, they are involved in the pathogenesis of diseases by damaging DNA 
and proteins causing gene modifications by altering the protein structures and functions, while 
glycoxidative damage and oxidative degeneration of lipids in cell membranes can also be a result 
(Carocho & Ferreira, 2013). The body defense mechanism generally declines with age, and can 
be compromised by various forms of oxidative stress from environmental factors to cancer, 
diabetes, atherosclerosis, and neurodegenerative disorders. All these conditions, as well as the 
aging process, are associated with oxidative stress due to the elevation of ROS or insufficient 
ROS detoxification (Limon-Pacheco & Gonsebatt, 2009; Igwe & Echeme, 2014). Oxidative 
stress therefore occurs when the formation of bioactive oxidative products such as oxidizing 
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agents, free radicals and reactive oxygen species, greatly overwhelms the capacity of the 
endogenous cellular antioxidant defense system, thus leading to potential damage of the cells and 
organs and to the progression of degenerative diseases in humans (Schrader & Fahimi, 2006; 
Basu, 2010). 
1.6 Tyrosinase 
Tyrosinase is a copper-containing enzyme present in animal, plant and human tissues. It 
catalyzes two distinct reactions using molecular oxygen (O2): hydroxylation of tyrosine to 3,4 – 
dihydroxyphenylalamine (DOPA) by monophenolase action and oxidation of DOPA to DOPA-
quinone by diphenolase action (Figure 1.4), which is considered as rate-limiting enzyme for 
controlling the production of melanin pigment that plays a vital role as a photo-protective agent 
against the harmful effects of UV radiation thereby absorbing UV light and removing reactive 
oxygen species (Summers, 2006; Mapunya & Nikolova, 2012). Melanin is produced naturally 
during a physiological process called melanogenesis by specific cells shown as melanocytes, 
which are distributed in the basal layer of the dermis (Baurin, et al., 2002). 
In food industry, tyrosinase is a very important enzyme in controlling the quality of foods, fruits 
and vegetables. It catalyzes the oxidation of phenolic compounds to the corresponding quinones 
responsible for the browning of fruits and vegetables during post harvesting (Huang, et al., 
2006).  
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Source: www.pub.rcs.org 
Figure 1.4: Monophenolase and diphenolase cycle of tyrosinase 
 
1.7 Natural product as source of tyrosinase inhibitors 
Discovering of tyrosinase inhibitors from natural source is of great importance in cosmetic 
products formulation for the prevention of skin hyperpigmentation (Chen, et al., 2015). 
Enzymatic browning of agricultural products during post harvesting is a common phenomena 
resulting into a decrease in nutritional quality and economic depreciation of such products 
(Mayer, 1987; Whittaker, 1995; Friedman, 1996). Hyperpigmentation in human skin and 
enzymatic browning in fruits are undesirable, so the occurrence of these unpleasant changes have 
motivated researchers to seek for new potent tyrosinase inhibitors for use as anti-browning and 
skin depigmenting agents (Kim & Uyama, 2005). There are numerous tyrosinase inhibitors from 
natural source such as hydroquinone, aloesin, arbutin, kojic acid and glabridin. However, the 
effectiveness of these products is of reasonable doubt owing to overtime adverse effects. An 
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example for this claim is carcinogenic effect demonstrated by kojic acid (Fuyuno, 2004), skin 
irritation, mutagenic effects to mammalian cells and cytotoxic to melanocytes demonstrated by 
hydroquinone (Curto, et al., 1999; Parvez, et al., 2006), and poor skin penetrations and stability 
demonstrated by aloesin and glabridin (Hermanns, et al., 2000). Thus it is in great need to seek 
for new potent tyrosinase inhibitors from natural source with reasonable human safety limits. 
1.8 Why investigate the family Lamiaceae 
The family Lamiaceae comprises approximately 980 species in Southern Africa which are 
mainly found in the Mediterranean, Central Asia and Sub-Sahara Africa regions, and display 
enormous morphological diversity (Klopper, et al., 2006). There are widely distributed in South 
Africa and comprises about 255 species assigned to 35 genera (Szentmihályi, et al., 2004; 
Strelitzia, 2013). Most of these plants possess aromatic sweet smell and widely used as culinary 
herbs and skin-care products (Lee, et al., 2011). The South African plants species of this family 
(e.g. Salvia) are used locally in the treatment of colds, coughs and bronchial infections. 
Industrially, these plants are widely employed as food additives, cosmetic formulations, 
aromatherapy and insecticides (Kamatou, et al., 2008). Tetradinia riparia has also been used 
traditionally in the treatment of coughs, dropsy, diarrhea, fever, headaches, malaria and 
toothaches (Gazim, et al., 2010), while Plectranthus ecklonii is used in the treatment of skin 
disorders, nausea, vomiting and cancer (Burmistrova, et al., 2015). Other notable economic value 
of plant species of this family is highlighted in the literature review presented in the next 
Chapter. 
1.9 Statement of research 
The process of pigmentation caused by over accumulation of melanin in specific parts of the skin 
is due to a prolong exposure of the human skin to the UV radiation, resulted into over 
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accumulation of free radicals in the body. This condition caused the stimulation of skin 
degenerative action of tyrosinase enzyme resulting into the formation of unpleasant skin 
pigmented patches as one of the factor of premature skin aging. Enzymatic browning of 
perishable agricultural products after post harvesting is another detrimental effect of tyrosinase 
enzyme, thereby reducing the nutritional quality and depreciation market value of such products. 
It is noteworthy to state that tremendous effort has been achieved by scientists towards 
combating the problem associated with skin pigmentation. One of such landmark achievement is 
the invention of sun screen for absorbing UV radiation. Regrettably, apart from the recent 
shortcomings of the usage of sunscreen, it is not affordable for the people of the continent.  
Hence there is urgent need to search for more potent skin depigmenting agents that can replace 
already listed agents as illustrated in section 1.6 due to their various bottlenecks.  
Lamiaceae plant species are widely distributed in South Africa and are readily available for 
human exploration for their potential application as anti-pigmenting agents. It is an established 
fact that this family contains phenolic compounds such as flavonoids, phenolic acid and 
diterpenes which are expected to play an important role in controlling undesirable skin 
conditions. Numerous plant species of this family such as Lavandula species, Origanum 
majorana, Ballota nigra, Eremostachys laevigota Burge have been reported to display potent 
tyrosinase inhibitory activity and also as antioxidant (Lee, et al., 2011; Hashemi & Zarei, 2014). 
Therefore, it is of great need in searching further for potent natural tyrosinase inhibitors from 
Lamiaceae plant species with proposition of replacing unsafe products readily available in the 
market. Further hypothesis was made to investigate the degree of antioxidant capacities in an in 
vitro system in order to complement the natural antioxidant already existing in the body through 
dietary intakes.  
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1.10 Aims of this study 
The main aim of this project is directed towards the preliminary screening of South African 
plants species belonging to Lamiaceae for their potency of tyrosinase inhibitory activity using 
different complementary assays such as thin layer chromatography (TLC) bioautography, 
spectrophotometry and cyclic voltammetry methods. The outcome of this screening will be used 
as prerequisite to nominate the bioactive plant materials for chromatographic isolation. 
Compounds emanated from such chromatographic isolation will be fully characterized 
chemically and biologically, and finally established their various structure-activity relationship 
between the compound (s) and their biological specificity demonstrated therefrom. 
1.11 Objectives of this study 
The main objectives of the study are: 
 Collection, documentation and identification of Lamiaceae plants. 
 Extraction of each plant materials with methanol. 
 Conduct the preliminary phytochemical screening on the methanolic extracts to identify 
various classes of compounds. 
 Carry out the preliminary biological screening using TLC bio-autographic and 
colorimetric assays on the methanolic extracts. 
 Investigate the tyrosinase inhibition current of the methanol extracts using cyclic 
voltammetry screening. 
 Perform chromatographic (TLC-guided column) isolation of bioactive constituents 
present in the most biologically and phytochemically active plant extract. 
 Perform final purification of chromatographic fractions using semi-prep HPLC to obtain 
compounds in pure state. 
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 Carry out structural elucidation of isolated compounds using different spectroscopic 
techniques. 
 Carry out biological investigations on the isolated compounds for their in vitro total 
antioxidant capacities. 
 Determine other biological characterization of the isolated compounds on tyrosinase 
inhibitory activity using spectrophotometric and cyclic voltammetry methods. 
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CHAPTER 2: A REVIEW OF SOUTH AFRICAN LAMIACEAE: 
TRADITIONAL, PHYTOCHEMISTRY AND BIOLOGICAL 
IMPORTANCE 
2.1 Introduction 
The aim of this chapter is to review the South African plant species of Lamiaceae from their 
ethno-medicinal perspective to the existing scientific data as depicted from Scifinder. The 
comprehensive review includes highlights on the phytochemistry of the family and their 
respective biological and pharmacological importance as applicable to this study. 
2.2 South African Lamiaceae family 
Lamiaceae is a family of flowering plants with 233 to 263 genera and 6900 to 7200 species 
(Kaurinovic, et al., 2010), which are classified into seven (7) subfamilies such as Ajugoideae 
kostel, Lamioideae Harley, Nepetoideae (Dumort) Luerss, Prostantheroideae Luerss, 
Scutillarioidea (Dumort) Caruel, Symphorematoideae Briq and Viticodeae Briq (Theodoridis, et 
al., 2012). They are mainly found in Mediterranean, Central Asia and Sub-Saharan Africa region. 
An approximation of 980 southern Africa species is widespread and display enormous 
morphological diversity. South African floral contains about 255 species assigned to 35 genera 
(Klopper, et al., 2006). Most of these plants are aromatic with fragrance smells and are widely 
used as culinary herbs and skin-care cosmetics traditionally (Lee, et al., 2011).  
2.2.1 Plant Morphology: Description and distribution 
The leaves of the plants belonging to Lamiaceae are opposite or whorled, decussate and gland-
dotted, while the flowers are usually bisexual arranged in compact auxiliary cymes. 
Zygomorphic flowers are characteristic of this family with calyxes usually persistent with 5 
lobes. However, actinomorphic (regular) with 4 or 5 lobed flowers occur in some genera (Raja, 
2012). The corolla is tubular and typically 2-lipped with 2 lobed upper lips and 3 lobed lip, 
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variously colored and are hairy most of the time. The species are predominantly abundant in 
summer compared to the winter in rainforest areas. The often habitats for the plants are rocky, 
woodland or grassland, but also occur along forest margins and in fynbos (Strelitzia, 2013). 
2.3 Traditional and biological uses of Lamiaceae plant species 
The use of traditional medicine plays a vital role in South Africa and constitutes the backbone of 
rural areas where 70 % of the population relies on traditional medicine for their primary health 
care needs (Scott & Springﬁeld, 2004). Numerous plant of Lamiaceae such as Salvia species 
have been used in South Africa to treat different kind of diseases including fever, digestive 
disorders, rheumatism, sexual debility, loss of memory, inflammation, microbial infections,  and 
cancer (Kamatou, et al., 2005). Salvia species have been reported to have anti-inflammatory and 
antioxidant properties and their traditional usage include in the treatment of wounds (Kamatou, 
et al., 2008). Plectranthus species are plant of economic and medicinal value, and numerous 
species are used in South Africa as traditional medicines for the treatment of various diseases 
such as cough, wounds, gastrointestinal disorders, and skin infections (Maree, et al., 2014). 
Tetradenia riparia have been assessed to be very potent in the treatment of common skin 
ailments in many rural communities of South Africa, and the herbal plant has been found to be 
the most frequently used by traditional healers for the treatment of cough and chest related 
diseases (Ndamane, et al., 2013). More details about the traditional uses of Lamiaceae plants 
species are highlighted on the Table 2.1 as follows. 
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Table 2.1: Medicinal uses and biological activities reported on South African plant species of 
Lamiaceae  
Name of the plant Traditional/Biological uses Reference 
Ballota africana  Fever, cough, asthma, influenza, 
insomnia, stress, sores 
(Scott & Springﬁeld, 2004; Lall 
& Kishore, 2014) 
Leonotus leonurus Skin infections, skin rashes, eczema, 
boils, bronchitis, cough, influenza, 
menstrual disorders, wound healing, 
asthma, cold, antioxidant, anti-
inflammatory, dermatological 
disorders 
(Scott & Springﬁeld, 2004; 
Mazimba, 2015) 
L. ocymifolia  Skin irritation, eczema, diabetes, 
hypertension, anemia, purgative 
(Scott & Springﬁeld, 2004) 
Mentha longifolia  Ulcerative colitis, liver complaints, 
anti-inflammatory, analgesic, 
antiplasmodic, anti-mutagenic, sores, 
wound, urinary tract antioxidant 
(Scott & Springﬁeld, 2004; Lall 
& Kishore, 2014) 
Plectranthus 
ambiguus 
Anti-oxidant (Liu & Ruedi, 1996) 
P. barbatus 
 
Respiratory ailments, liver 
disturbance, heart diseases, nervous 
problems 
(Reis, et al., 2015) 
 
 
P. ecklonii 
 
Skin disorders, stomachaches, nausea, 
vomiting, meningitis, cancer 
 
(Burmistrova, et al., 2015) 
Salvia africana-
caerulea 
Stomachache, headache, bronchial 
congestion, antiseptic wash to ulcer 
(Scott & Springﬁeld, 2004) 
S. africana- lutea Cough, sexual debility, throat 
inflammation, chronic bronchitis, 
tuberculosis, influenza, diarrhea, 
anticancer, anti- inflammatory, 
antioxidant  
(Scott & Springﬁeld, 2004; 
Nkomo, et al., 2014) 
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S. aurita Antioxidant, anti-inflammatory (Fisher, 2005) 
S. chamelaeagnea Cough, whooping cough, bronchitis, 
cold, flu, diarrhea, stomachache, 
headache, fever, burn wounds, 
microbial infections, antioxidant 
(Huang & Van Staden, 2002; 
Scott & Springﬁeld, 2004; 
Kamatou, et al., 2007) 
S. disermas Sores, rheumatism, hypertension, 
antioxidant, antimicrobial, 
antituberculosis, anti-inflammatory, 
antiplasmodial  
(Fisher, 2005; Hawas, et al., 
2009) 
S. dolomitica Anti-inflammatory (Kamatou, et al., 2008) 
S. namaensis Antioxidant (Kamatou, et al., 2008) 
S. radula Antioxidant, anti-inflammatory (Kamatou, et al., 2008) 
S. repens Sores on the body, stomach problem, 
diarrhea, anti-inflammatory, anti-
oxidant 
(Kamatou, et al., 2005) 
S. runcinata Antioxidant, fever, anti-inflammatory, 
purgative, headache 
(Kamatou, et al., 2005) 
S. stenophylla Antioxidant, anti-inflammatory, 
disinfectant, purgative, cold, cough, 
chest congestion 
(Kamatou, et al., 2005; Lall & 
Kishore, 2014) 
Tetradenia riparia Cough, whooping, bronchitis, cold, 
diarrhea, headache, dropsy, fever, 
stomach ache, burn wounds, 
antiseptic, toothaches, skin diseases, 
and antioxidant. 
(Scott & Springﬁeld, 2004; 
Gairola, et al., 2009; Ndamane, 
et al., 2013) 
 
2.4 Phytochemistry of Lamiaceae 
The chemistry of Lamiaceae family is still scanty with little chemical characterisation, but a 
large number of diterpenoids including kauranes, abietanes, clerodanes, phyllocladenes, 
neoclerodane, labdanes, pimiranes, isopimaranes, beyeranes, sesquiterpenes, and flavonoids are 
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widely found in different species of Plectranthus genus (Abdel-Mogib & Albar, 2002). Salvia 
species have been reported to be rich source of phenolic and polyphenolic compounds such as 
carnosic acid (8), rosmarinic acid (21), caffeic acid (20) (Table 2.3.3 and 2.3.5) (Hamidpour, et 
al., 2014). It has been reported that the genus Ballota is rich in diterpenoids especially clerodane 
and tetracyclic diterpenes, the aromatic fragrance smell is an indication that characterized the 
plant of this genus (Ahmad, et al., 2004). Widespread occurrence of flavonoids, labdane 
diterpenoids, monoterpenoids and sesquiterpenoids in Tetradenia genus is an indication that 
characterized the plant from this genus (Mazimba, 2015). Lamiaceae family is a source of 
flavonoids and phenolic acid compounds such as rosmarinic acid (21), p-coumaric acid, caffeic 
acid (20), ferulic acid, chlorogenic acid, luteolin (22), apigenin (23) (Table 2.3.5 and 2.4.1), 
genkwanin, quercitrin, rutin, epicatechin and catechin (Lee, et al., 2011). Caffeic acid is very 
common in Salvia species and the majority of phenolic acids isolated from Salvia are derivatives 
of caffeic acid which is the building block of a variety of plant metabolites (Kamatou, et al., 
2009). Caffeic acid plays a vital role in the biochemistry of Lamiaceae and occurs predominantly 
in a dimer form as rosmarinic acid (Table 2.3.5) (Hamidpour, et al., 2014). The chemistry and 
the biological importance of the isolated compounds from Lamiaceae with skin anti-aging 
properties such as anti-tyrosinase, anti-melanogenesis, antioxidant, anti-inflammatory and 
antibacterial are highlighted on the tables (Table 2.2,  2.3, 2.4, … etc.) below. 
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Table 2.2: Selected secondary metabolites with anti-ageing properties 
Table 2.2.1: Monoterpenes 
S/N Compound Plant source Biological activity Reference 
1 
O
O
CH3
 
    Linalyl acetate  
S. dolomitica Anti-inflammatory (Kamatou, et al., 2008) 
 
2 OH
 
Linolol 
S. dolomitica Anti-inflammatory (Kamatou, et al., 2008) 
 
S: Salvia 
Table 2.2.2: Sesquiterpene 
S/N Compound  Plant source  Biological activity Reference  
3 OH
 
∝ − bisabolol 
S. runcinata Antioxidant 
Anti-inflammation 
(Kamatou, et al., 2008)
 
 
S: Salvia 
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Table 2.2.3: Abiatene diterpenoid 
S/N Compound  Plant source  Biological activity Reference  
4 O
HO
RO
 
Parvifloron D 
P.ecklonii Antioxidant 
 
 
 
(Rosa, et al., 2015) 
 
 
 
P: Plectranthus 
Table 2.2.4: Labdane diterpenoids 
S/N Compound  Plant source  Biological activity Reference  
5 
 
O
O
O
CH3
H3C
HO
 
Marrubin 
L. leonurus 
 
Antioxidant 
 
(Mazimba, 2015) 
6 
O
O
 
Leoleorin C 
L. leonurus 
 
Antioxidant 
 
 
(Mazimba, 2015) 
 
 
L: Leonotus 
 
 
 
 
 
 
 
http://etd.uwc.ac.za/
CHAPTER 2: LITERATURE REVIEW 
 
20 
 
Table 2.2.5: Phenolic diterpenes 
S/N Compound  Plant source  Biological activity Reference  
7 
 
OH
O
O
HO
 
   Carnosol 
S. chamelaeagnea 
 
Antioxidant  
Anti-melanogenic 
Antibacterial 
(Kamatou, et al., 2009)
a 
(Shirasugi, et al., 2010)
b 
(Kamatou, et al., 2007)
d 
8 
 
 
OH
HO
HOOC
 
    Carnosic acid 
R.officinalis Antioxidant  
Anti-inflammatory 
 
 
 
(Oliveira, et al., 2016)
a 
(Bai, et al., 2010)
b 
 
9 
 
 
 
    Rosmanol 
R. officinalis Antioxidant (Inatani, et al., 1982) 
10 
 
OH
O
H
CHO
CHO
O
 
Rosmadial 
S. officinalis 
 
Antioxidant 
 
 
(Brewer, 2011) 
 
OH
OH
O
OH
O
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11 
OH
HO
OH
O
O
 
epirosmanol 
S. officinalis 
 
Antioxidant (Miura, et al., 2002) 
 
 
12 
OH
HO
O
OC2H5
O
 
  7- ethoxy-rosmanol 
S. officinalis 
 
 
 
 
Antioxidant 
 
 
(Miura, et al., 2002) 
 
13 
 
OH
HO
O
OC2H5
O
 
7-O-methylepirosmanol 
 
S. namaensis 
 
Antioxiant 
 
(Kamatou, et al., 2009) 
14 OH
HO
O
O
O
 
    galdosol 
S. officinalis 
 
Antioxidant (Miura, et al., 2002) 
15 OH
HO
O
H
O
 
isorosmanol 
S. officinalis 
 
Antioxidant (Miura, et al., 2002) 
 
16 
  
 
 
Antioxidant 
 
(Gazim, et al., 2014) 
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O
O
OH
 
6,7- dehydroroyleanone 
T. riparia 
a: antioxidant; b: anti-melanogenesis; d: antimicrobial; S:Salvia; R:Rosmarinus; T:Tetradenia 
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Table 2.2.6: Triterpenes 
S/N Compound  Plant source  Biological 
activity 
Reference  
17  
 
Ursolic acid 
S. officinalis 
 
 
 
Anti-
inflammatory 
Antibacterial 
(Baricevic, et al., 
2001)
c 
(Horiuchi, et al., 
2007)
d 
18 
 
 
HO
COOH
 
         Oleanolic acid 
S. chamelaeagnea 
 
 
Antioxidant 
Anti-
inflammatory 
Antimicrobial 
(Kamatou, et al., 
2007)
a 
(Hwang, et al., 
2014)
c 
(Horiuchi, et al., 
2007)
d 
19  
HO
OH
O
OH
 
betulafolientriol oxide 
S. radula Antioxidant (Kamatou, et al., 
2009) 
a: antioxidant; c: anti-inflammatory; d: antimicrobial;S: Salvia 
 
COOH
HO
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Table 2.2.7: Phenolic acid 
S/N Compound  Plant source  Biological activity Reference  
20 
 
 
HO
HO
OH
O  
    Caffeic acid 
S. muirii Antioxidant  
Anti-melanogenic 
 
 
(Kamatou, et al., 2009)
a 
(Thangboonjit, et al., 
2014)
b 
21  
HO
HO
O
O
OH
OH
COOH
 
        Rosmarinic acid 
R.officinalis Anti-inflammatory 
Antioxidant 
Anti-melanogenic 
 
(Petersen & Simmonds, 
2003)
a,c 
(Oliveira, et al., 2013)
b 
a:antioxidant; b:anti-melanogenesis; c: anti-inflammatory; S: Salvia;R: Rosmarinus 
 
Table 2.2.8: Flavones  
S/N Compound  Plant source  Biological 
activity 
Reference  
22 
O
OH
HO
O
OH
OH
 
Luteolin 
Teucrium 
.chamaedrys 
 
 
Antioxidant 
Anti-
inflammatory 
 
(Panovska, et al., 
2005)
a 
(Lopez-Lazaro, 
2009)
c 
23 
 
O
OH
HO
O
OH
 
       Apigenin 
T. polium Antioxidant (Panovska, et al., 
2005) 
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24 
O
OH
HO
O
OH
OCH3
 
        Diosmetin 
T. polium Antioxidant (Panovska, et al., 
2005) 
25 
O
OH
HO
MeO
OMe
O  
           Ladanein 
P. ambiguus Antioxidant 
 
 
(Liu & Ruedi, 
1996) 
 
 
26 
O
O
H3CO
H3CO
OCH3
OH
 
Salvigenin 
S. radula Antioxidant (Kamatou, et al., 
2009) 
a: antioxidant; c: anti-inflammatory; T: Teucriun; P: Plectranthus; S: Salvia  
Table 2.2.9: Phenylpropenoid 
S/N Compound  Plant source  Biological 
activity 
Reference  
27  
HO
HO
O
O
OH
OH
O
OH
OH
OH  
    salvianolic acid 
S. officinalis Antioxidant 
 
(Lu & Foo, 
2001) 
S: Salvia 
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2.5 Biological activities of Lamiaceae 
2.5.1 Anti-tyrosinase activity 
Based on the available information on the SciFinder database, there is no report on South African 
Lamiaceae plant species with significant activity against tyrosinase enzyme. However, it has 
been documented that the methanol extract of the aerial part of S. africana lutea demonstrated 
marginal inhibition of tyrosinase with inhibition of 48 % and 36 % at 500 μg/mL using tyrosine 
and L-DOPA as substrate (Momtaz, et al., 2008). The unpublished result conducted on the ethyl 
acetate fraction of P. ecklonii demonstrated moderate anti-tyrosinase inhibition with IC50 = 61.73 
± 2.69 µg/mL (Nyilan & Lall, 2010). 
Nevertheless, there are numerous plants species of this family from other geographical locations 
reported to have significant tyrosinase inhibitory activity. Such example with significant 
inhibition are indicated in Table 2.6 
Table 2.3: Plant species with tyrosinase inhibitory activities 
Name of the plant Location  IC50 (µg/mL) Reference 
Origanum majorana Taiwan 107.00 (Lee, et al., 2011) 
Lavendula stoechas   Taiwan 127.00 (Lee, et al., 2011) 
Lavendula latifolia Taiwan 145.00 (Lee, et al., 2011) 
Lavendula allardu Taiwan 113.00 (Lee, et al., 2011) 
Ballota nigra   Iran 3.67  (Hashemi & Zarei, 2014) 
Eremostachys laevigota  Iran 9.51  (Hashemi & Zarei, 2014) 
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2.5.2 Antioxidant activities 
The family Lamiaceae is considered to be a promising source of natural antioxidants by the fact 
that polyphenolic sincluding carnosol (7), rosmanol (10) (Table 2.3.3) are the predominant 
components of this family and it has been reported to possess good antioxidant activities 
(Kamatou, et al., 2009). It has been established that there is a relationship between the chemical 
structure and antioxidant activity demonstrated by each constituents. The increase in number of 
hydroxyl groups in the aromatic ring increased with the free radical-scavenging and antioxidant 
activities (Lee, et al., 2011). The South African Salvia species were found to display good 
antioxidant activity with DPPH (IC50 1.66-74.50 µg/mL), while ABTS
.+ showed IC50 values 
between the range of 11.88 to 69.26 (Kamatou, et al., 2008). The antioxidant values displayed by 
the South African Salvia are mainly attributed to the presence of phenolics including phenolic 
acid such as rosmarinic acid (21), carnosic acid (8) and carnosol (7) as indicated in Table 2.3.3 
and 2.3.5 (Huang & Van Staden, 2002; Petersen & Simmonds, 2003). Other compounds that 
may contribute to the antioxidant activities of Salvia include the presence of polyphenolic 
compounds such as flavonoids (Exarchou, et al., 2002; Kouřimská, et al., 2013). Teucrium 
species have been reported to possess radical scavenging activity as well as antioxidant activity 
in an in vitro system (Panovska, et al., 2005). 
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CHAPTER 3: PRELIMINARY PHYTOCHEMICAL AND BIOLOGICAL 
SCREENING OF SELECTED SOUTH AFRICAN LAMIACEAE 
3.1 Introduction 
This chapter describes the preliminary phytochemical and biological investigation of South 
African Lamiaceae collected in the Cape floristic region. 
The preliminary phytochemical screening was carried out with TLC using different solvent 
system and detection the spot physically (UV, short and long wavelengths) and chemically using 
vanillin/H2SO4 spray. 
 The preliminary biological (anti-tyrosinase activity) screening of the methanolic extracts of 25 
South African Lamiaceae involved the following methods: 
 TLC bioautography, a quick and simple screening method for detection of tyrosinase 
inhibitors. It is commonly used for bio-guided fractionation of tyrosinase inhibitors from 
mixtures or extracts (Wangthong, et al., 2007). 
 Spectrophotometric measurement as the most widely used and reliable methodfor 
detection of tyrosinase inhibitors due to its best sensitivity, selectivity and versatility 
(Xia, et al., 2013). 
 Cyclic voltammetry measurement, an electrochemical technique in which the current is 
measuring between a working and counter electrode as a function of the potential 
(Aristov & Habekost, 2015). CV is commonly used for detection of phenolic compounds, 
antioxidant agents (Dobes, et al., 2013; Magarelli, et al., 2013). However, this method 
has not been reported previously to measure or predict tyrosinase activity of plant 
extracts. So this is the first report on screening of tyrosinase inhibitors from natural 
source using cyclic voltammetry as a tool for detection of tyrosinase inhibitors. 
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3.2 Materials and methods 
3.2.1 Plant materials 
Some of the plant materials used in this study were sourced from Kirstenbosch Garden Centre 
and the Nursery at the Cape Flats Nature Reserve, Bellville, while others were collected in the 
Cape Flats Nature Reserve and Hantam National Botanical Garden, Nieuwoudtville (Table 3.1). 
The wild collected plants were identified at the Compton Herbarium, Kirstenbosch by Dr. 
Christopher Cupido (SANBI, Kirstenbosch); a voucher specimen of each plant was deposited at 
the Compton Herbarium at Kirstenbosch. 
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Table 3.1: List of the collected plant species 
Assigned Code Name of the plant Place of collection  
S1 Ballota africana Hantam National Botanical Gardens          
S2 Leonotis leonurus Cape Flats Nature Reserve   
S3 L. nepetifolia Cape Flats Nature Reserve   
S4 Mentha longifolia Kirstenbosch Garden Centre 
S5 Plectranthus ambiguus Kirstenbosch Garden Centre 
S6 P. ciliates Cape Flats Nature Reserve   
S7 P. ecklonii Kirstenbosch Garden Centre 
S8 P. fruticosus Kirstenbosch Garden Centre 
S9 P. grandidentatus Kirstenbosch Garden Centre 
S10 P. hadiensis Kirstenbosch Garden Centre 
S11 P.  madagascariensis Cape Flats Nature Reserve 
S12 P. saccatus Cape Flats Nature Reserve 
S13 P. strigosus Kirstenbosch Garden Centre 
S14 P. verticillatus Kirstenbosch Garden Centre 
S15 P. zuluensis Kirstenbosch Garden Centre 
S16 Salvia africana-caerulea Cape Flats Nature Reserve 
S17 S. chamelaeagnea Kirstenbosch Garden Centre  
S18 S. disermas Hantam National Botanical Gardens          
S19 S. dolomitica Kirstenbosch Garden Centre 
S20 S. lanceolate Kirstenbosch Garden Centre 
S21 S.  muirii Kirstenbosch Garden Centre 
S22 S. namaensis Kirstenbosch Garden Centre 
S23 Stachys rugose Hantam National Botanical Gardens          
S24 Tetradenia riparia Kirstenbosch Garden Centre 
S25 Thorncroftia succulenta Kirstenbosch Garden Centre 
 
 
 
 
 
http://etd.uwc.ac.za/
CHAPTER 3: PHYTOCHEMICAL AND BIOLOGICAL SCREENING 
 
32 
 
3.2.2 Preparation of plant extracts 
The fresh aerial parts of the fresh plant materials were blended and extracted with methanol for 
24 hours at room temperature (25 oC). The methanol extracts were filtered and evaporated to 
dryness under reduced pressure at 40 oC. The extracts were kept under cold conditions for further 
use. 
3.2.3 Chemical and Reagents 
The mushroom tyrosinase (EC 1.14.18.1) 5771 Unit/mg, L-Tyrosine and Kojic acid were 
purchased from Sigma Aldrich (Cape Town, South Africa). Organic solvents such as methanol 
(MeOH), ethanol (EtOH), hexane, dichloromethane (DCM), ethyl acetate (EtOAc), and dimethyl 
sulfoxide (DMSO) were supplied by Merck (Cape Town, South Africa). Thin layer 
chromatography (TLC) was conducted on normal-phase silica gel 60 PF254 pre-coated aluminium 
plates (Merck, Cape Town, South Africa).  
3.2.4 Apparatus 
All spectrophotometry experiments were performed using the enzyme-linked immunosorbent 
assay (ELISA) on AccuReader M 965/965+, Metertech Inc. version 1.11, Taipei, Taiwan. The 
cyclic voltammetry was performed using BASI EPSILON system as potentiostat. Three 
electrodes were used such as glass carbon electrode as a working electrode, a platinum (Pt) wire 
electrode as a counter electrode and an auxiliary electrode Ag/AgCl as reference electrode. The 
cyclic voltammetry experiments were recorded at 50 mV/s or 25 mV/s in two different potential 
ranges comprised between -1300 and 1300 mV; -200 and 200 mV. All experiments were 
performed at room temperature.   
 
 
 
 
http://etd.uwc.ac.za/
CHAPTER 3: PHYTOCHEMICAL AND BIOLOGICAL SCREENING 
 
33 
 
3.2.5 TLC bioautographic assay for tyrosinase inhibition 
The TLC bioautographic assay of tyrosinase inhibition was performed as described previously 
(Wangthong, et al., 2007) with slight modifications. Phosphate buffer (PBS) was prepared by 
mixing two stock solutions of monosodium phosphate 50 mM and disodium phosphate 50 mM to 
the pH 6.5.Tyrosinase solution was prepared by dissolving 1 mL of 1000 U enzyme in 1 mL of 
phosphate buffer. The substrate was prepared by dissolving 0.0036 g of L-tyrosine in 10 mL 
phosphate buffer. Extracts and kojic acid were dissolved in methanol to a stock solution of 1 
mg/mL, 15 µL of the extracts and kojic acid (as positive control) were spotted onto the TLC 
plate and the plate was developed using two different solvent systems Hex:EtOAc (9:1) and 
DCM:MeOH (97:3). The developed plate was sprayed with tyrosinase and incubated at room 
temperature for 5 min, followed by L-tyrosine (20 mM) and left at room temperature for 30 min, 
then photographed. 
3.2.6 Tyrosinase enzyme Assay 
This assay was performed using spectrophotometric method as previously described (Popoola, et 
al., 2015). Samples were dissolved in DMSO to a stock solution of 1 mg/mL, and further 
dilutions were done with 50 mM sodium phosphate buffer (pH 6.5) for all working solutions. 
Kojic acid was used as positive control. In the wells of a 96-well plate, 70 µL of each sample 
working solution was combined with 30 𝜇L of tyrosinase (500 Units/mL in sodium phosphate 
buffer) in triplicate. After incubation at room temperature for 5 min, 110 𝜇L of substrate (2 mM 
L-Tyrosine) was added to each well. Incubation commenced for 30 min at room temperature and 
the enzyme activity was determined by measuring the absorbance at 490 nm. The percentage of 
tyrosinase inhibition was calculated as follows: 
(%) = [(A - B) - (C - D)]/ (A - B) × 100 (1) 
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Where A is the absorbance of the control with the enzyme, B is the absorbance of the control 
without the enzyme, C is the absorbance of the test sample with the enzyme and D is the 
absorbance of the test sample without the enzyme. 
3.2.7 Cyclic voltammetry measurement 
Cyclic voltammetry was used for monitoring the behavior (increase or decrease) of the inhibition 
current with time in the presence of kojic acid or extract(s). 
It was performed using the BAS100B electro-chemical analyzer, a glassy carbon electrode 
(GCE) as working electrode, Ag/AgCl as a reference electrode and platinum (Pt) as a counter 
electrode. Cyclic voltammograms (CVs) were recorded at two different scan rates 50 mV/s and 
25 mV/s within the potential window ranging from -1300 to 1300 mV and from -200 to 200 mV. 
Both extracts and kojic acid were made to a stock solution of 10 mg/mL with DMSO. Tyrosinase 
and L-tyrosine were diluted in phosphate buffer to a working concentration and the experiments 
were carried out at room temperature. 
In CV experiments, glassy carbon electrode was polished with emery paper and Alumina powder 
(1.0, 0.3, 0.05 µm) to a minor finish, and then sonicated in doubly purified using ethanol and 
distilled water for 15 min each. After each CV scan, the electrode was re-polished using the same 
procedure to maintain the consistency of the surface area of the electrode. 
To a cell containing 10 mL of 50 mM PBS at pH 6.5, a fixed volume of extracts and tyrosinase 
enzyme were added (700 𝜇L) and (300 𝜇L) respectively, to which a specific volume of the L-
tyrosine (1100 𝜇L) was also added. To understand the activity of the control either positive or 
negative, the extract was replaced with kojic acid and DMSO. Cyclic voltammetry of each 
addition was recorded. 
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3.3 Results and Discussion 
In the search of discovering new natural tyrosinase inhibitors, three complementary methods 
such as TLC bioautography, spectrophotometric and cyclic voltammetry were used for screening 
the selected plant extracts against tyrosinase. However, ELISA is predominantly used, the TLC 
bioautography has been reported for the same purpose while the use of cyclic voltammetry for 
the detection of tyrosinase inhibitors was limited to detect phenolic compounds through 
electrochemical measurement.  
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Table 3.2:  Percentage yield of the plant extracts 
Name of the plant Weight of the plant (g) Weight of the extract (g) % Yield 
Ballota africana 797.5 74.2 9.3 
Leonotis leonorus 134 10.1 1.32 
L. nepetifolia 89.8 10.6 11.8 
Mentha longifolia 10.1 1.9 18.8 
Plectranthus ambiguus 88.8 2.1 2.36 
P. ciliates 202.5 3.9 1.92 
P. ecklonii 130.2 8.5 6.51 
P. fruticosus 113.7 4 3.52 
P. grandidentatus 197.4 5 2.5 
P. hadiensis 138.7 3.8 2.74 
P. madagascariensis 294.5 4.5 1.51 
P. saccatus 163.4 7.1 4.34 
P. strigosus 72.6 12.6 17.35 
P. verticillatus 494.8 9.4 1.89 
P. zuluensis 101.2 3.5 3.45 
Salvia africana-caerulea 55 16 29.1 
S. chameleagnea 1088.7 29.55 2.71 
S. disermas 541.1 40.3 7.44 
S. dolomitica 93.3 6.5 6.97 
S. lanceolate 63.8 16.4 25.7 
S. muirii 56.5 4.6 8.14 
S. namaensis 130.8 10.3 7.87 
Stachys rugosa 229.6 43 18.72 
Tetradenia riparia 170.2 8.1 4.79 
Thorncroftia succulent 167.4 5.3 3.16 
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3.3.1 Preliminary phytochemical screening 
The phytochemical screening of the selected plant species of Lamiaceae revealed the presence of 
many classes of compounds as shown on the TLC plate (Fig. 3.1). Such compounds include 
terpenoids (blue), flavonoids (yellow), and other phenolic compounds (red, orange). 
 
 
 
 
 
 
 
 
 
 
 
1-25: Extracts; Q: quercetin 
1-25: Extracts (S1-S25); Q : quercetin  
Figure 3.1: TLC silica gel of the phytochemical screening of the plant species, solvent system 
DCM:MeOH (9.5:05); under UV (254nm; A), and spraying with H2SO4/ vanillin then heated (B). 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24  5 2
5 
Q 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 Q 
A 
B 
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3.3.2 Cyclic voltammetry measurement 
It is well known that tyrosinase catalyzes the oxidation process of L-tyrosine to dihydroxy-
phenylalamine (L-DOPA) and from L-DOPA to dopaquinone (Ozer, et al., 2007). 
                     Tyrosinase                                 Tyrosinase 
                    (monophenolase)                        (diphenolase) 
Tyrosine L-DOPA  Dopaquinone 
                          + O2                                                                + O2 
 
CVs recorded for monitoring the enzymatic oxidation of L-tyrosine catalyzed by tyrosinase with 
time in the presence of molecular oxygen as shown in Figure 3.2. The broad-scan range set of 
CVs (from -1300 to 1300 mV at 50 mV/s) showed interesting electro-oxidation peak between -
200 to 200 mV (Fig. 3.2 A), which evolved only gradually, i.e. its peak current increasing with 
reaction time. This was attributed to the electron transfer reaction involving a product of the 
enzymatic reaction, in this case, dopaquinone, which accumulated in the reaction medium as 
time went by (Fauziyah, et al., 2012). This peak was confirmed to exist at about 131 mV 
independent of the other peaks by running another set of CVs in a narrower scan range (-200 and 
200 mV at 25 mV/s) as shown in Figure 3.2 B. Henceforth, this peak will be referred to as the 
inhibition peak and its peak current as the inhibition current (iinh) because it is expected to be 
affected by the presence of tyrosinase inhibiting agent. 
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Figure 3.2: CVs recorded at 50 mV/ s in wide scan range (A), and  at 25 mV/ s at the narrow 
scan range (B) for the reaction mixture of tyrosine and tyrosinase in 50 mM PBS (pH 6.5) at 
different times. Curve (a) 0 min, curve (b) 5 min, curve (c) 10 min, curve (d) 20 min, and then 
curve (e) 30 min. 
 
The inhibition peak for the same reaction mixture was next studied in the presence of kojic acid, 
a standard tyrosinase inhibitor (Chang, 2009) as a positive control, and DMSO as a negative 
control (blank). As shown in Figure 3.3, an oxidation peak was observed and the oxidation 
current increased in time from 8.99 X 10-3µA to 96 X 10-3µA at 131 mV, indicating that the 
oxidation of tyrosine catalyzes by tyrosinase have been demonstrated. Figure 3.3 B showed no 
redox peak and the inhibition current decreased and almost dropped to the background level in 
time, indicating that the activity of tyrosinase was inhibited by kojic acid. These results are in 
agreement with the previous work described (Xia, et al., 2013), and the proposed method will be 
applicable for screening tyrosinase inhibitors from natural sources. 
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                                  (A)                                                              (B) 
 
 
Figure 3.3: CVs recorded at 25 mV/ s for the reaction mixtures during negative control (A) and 
positive control (B) experiments, first for 50 mM PBS (pH 6.5) (curve a) and then after 
consecutive addition of DMSO (left, curve b) or kojic acid (right, curve b), tyrosinase (curve c), 
and tyrosine (0 min – curve d, 30 min- curve e). 
 
Based on the CVs, the inhibitory behavior of each extracts toward the enzyme were classified as 
either positive or negative depending on the similarity to CVs recorded by replacing the extract 
with kojic acid as positive control or DMSO as negative control. An inhibitory behavior was 
“positive” when the inhibition current decreased with time but “negative” when it increased with 
time. Such decisions were made based on the differences between CVs recorded at 0 min and 30 
min after addition of the substrate to a mixture of the extract and the enzyme in the buffer. 
Ultimately, the extracts were classified into two groups: active extracts and inactive extracts.  
Group 1: Extracts that behave as positive control by decreasing the inhibition current with time, 
indicating that the activity of tyrosinase was inhibited and were therefore refers to this group as 
<< active >>. 
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Group 2: Extracts that behave as negative control by increasing the inhibition current with time, 
indicating that the inhibition of tyrosinase doesn’t take place and were therefore tagged this 
group as << inactive >>. 
 
The histograms of each group were obtained by integrating the anodic area at the narrow 
potential ranging from 0.05 V to 200 V at 0 and 30 min after adding tyrosinase and tyrosine to 
the extract(s) or control(s) as shown in Figure 3.4. 
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Group 1: Active extracts                                             Group 2: Inactive extracts 
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Figure 3.4: Illustration of the effect of each group on inhibition of tyrosinase activity 
 
The results demonstrated that the tyrosinase inhibitory activity of the tested extracts and kojic 
acid obtained by measuring the inhibition current with time are in agreement with the previous 
work described (Xia, et al., 2013). It has been reported that during the screening of tyrosinase 
inhibitors using cyclic voltammetry, the current increase with the increase of tyrosinase 
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concentration and time in the absence of inhibitor, while the inhibition current decrease and 
almost dropped to the background level with the increase of kojic acid concentration and time, 
indicating that the activity of tyrosinase was inhibited by kojic acid (Xia, et al., 2013). 
All the active extracts including kojic acid decreased the inhibition current with time (from 0 to 
30min) as shown in Figure 3.4A, an indication that tyrosinase activity was inhibited by the 
extracts. The preliminary phytochemical investigation (Fig. 3.1) on the 25 plants (methanol 
extracts) revealed the presence of polyphenolic compounds as well as terpenoids when sprayed 
with vanillin sulfuric acid. The behavior of the inhibition current is due to the fact that the 
extracts contain phenolic constituents that have the properties to chelate or bind with the copper 
ions in the active site of tyrosinase, which result in its inhibition (Huang, et al., 2006). All the 
inactive extracts including DMSO increased of the inhibition current with time as shown in 
Figure 3.4B, an indication that there is no inhibition of tyrosinase by the tested extracts. This 
might be presumably related to their phytochemical constituents. Structural differences in 
phenolic compounds found in species of Lamiaceae family may also play a critical role in 
occurrence of tyrosinase inhibition (Suntar, et al., 2011). 
To evaluate the amenability of the method adopted, the tyrosinase inhibitory activity was 
determined by measuring the inhibition based on charge of each extracts and controls. The 
percentage of inhibition was calculated as follows. 
[(Q30' – Q0')/ Q0'] X 100 (2) 
Where  Q30' is the inhibition based on charge at 30 min, Q0' is the inhibition based charge at 0 
min,  
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Based on the result obtained in Table 3.3, 60 % of the plant extracts exhibited the percentage of 
inhibition more than 100, and were therefore refers as <<active>>, while 40 % of the extracts 
demonstrated the percentage of inhibition less than 100, and were therefore tagged as 
<<inactive>> 
Table 3.3: Inhibition based on charge of the extracts, positive and negative controls at 0 and 30 
min in the presence of tyrosinase and tyrosine obtained by integrating the anodic area from the 
corresponding CVs 
     
 
Abg A0' A30' Qbg Q0' Q30' Q30'-Q0' 
 
 
Area 
before 
rnx/10
-4
 
Area at 
0 
min/10
-4
 
Area at 
30 
min/10
-4
 Qbg/ mC 
Q0min/ 
mC 
Q30min/ 
mC DQ/ mC %DQref 
Ballota africana 7.39 8.97 14.2 29.56 35.88 56.8 20.92 95.7 
Leonotus leonurus 16.9 18.1 17.8 67.6 72.4 71.2 -1.2 100.2 
L. nepetifolia 8.24 11.7 32.8 32.96 46.8 131.2 84.4 82.8 
Mentha longifolia 12.9 24.9 17.8 51.6 99.6 71.2 -28.4 105.8 
Plectranthus ambiguus 17.2 26.5 23.7 68.8 106 94.8 -11.2 102.3 
P. ciliates 6.36 13 10.6 25.44 52 42.4 -9.6 102.0 
P. ecklonii 16.2 41.61 36.6 64.8 166.44 146.4 -20.04 104.1 
P. fruticosus 25.8 34.1 34.4 103.2 136.4 137.6 1.2 99.8 
P. grandidentatus 12.2 32 36.2 48.8 128 144.8 16.8 96.6 
P. hadiensis 31.6 62 64.1 126.4 248 256.4 8.4 98.3 
P. madagascariensis 2.91 12.3 7.83 11.64 49.2 31.32 -17.88 103.6 
P. saccatus 9.76 19.6 12 39.04 78.4 48 -30.4 106.2 
P. strigosus 14.3 23.1 16.1 57.2 92.4 64.4 -28 105.7 
P. verticillatus 16 29.4 38.1 64 117.6 152.4 34.8 92.9 
P. zuluensis 4.87 13.6 9.56 19.48 54.4 38.24 -16.16 103.3 
S. africana-caerulea 21.4 21.8 16.6 85.6 87.2 66.4 -20.8 104.2 
S.chamelaeagnea 6.06 10.7 7.78 24.24 42.8 31.12 -11.68 102.4 
S. disermas 8.88 14.3 19.2 35.52 57.2 76.8 19.6 96.0 
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S. dolomitica 8.91 11.1 9.01 35.64 44.4 36.04 -8.36 101.7 
S.lanceolata 9.81 24.8 14.9 39.24 99.2 59.6 -39.6 108.1 
S.  muirii 10.4 13.5 12.5 41.6 54 50 -4 100.8 
S. namaensis 5.24 6.96 6.24 20.96 27.84 24.96 -2.88 100.6 
Stachys rugosa 16.1 19.3 24.9 64.4 77.2 99.6 22.4 95.4 
Tetradenia riparia 21.5 24.3 30.5 86 97.2 122 24.8 94.9 
Thorncroftia succulenta 9.96 11.7 15.6 39.84 46.8 62.4 15.6 96.8 
Positive control 12.6 10.1 9.59 50.4 40.4 38.36 -2.04 100.4 
Negative control 13.8 12.8 107.3 55.2 51.2 429.2 378 0.0 
 
3.3.3 TLC bioautographic assay for tyrosinase inhibition 
The anti-tyrosinase bioautography assay was carried out on TLC plate developed with solvent 
systems Hex:EtOAc (9:1) and DCM:MeOH (97:3) respectively as indicated in Figure 3.5 (A & 
B). The plate was sprayed with both enzyme and the substrate and then incubated for 30 minutes. 
Clear white zones against the purple background, which were visually detected, are indication of 
zone of inhibition as demonstrated by respective extracts (Misra & Dey, 2012). The size of the 
white zones of inhibition is related to the degree of tyrosinase inhibition. Kojic acid 
demonstrated the highest zone of inhibition followed by Salvia chamelaeagnea, S. dolomitica, 
Plectranthus ecklonii, P. namaensis, and P. zuluensis. 
 
 
 
 
 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 KA 17 18 19 20 21 22 23 24 25 
A 
                       1-25 Extracts (S1-S25); KA: Kojic acid 
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Figure 3.5: TLC silica gel bioautography of all the extracts and kojic acid (A), the active 
extracts and kojic acid (B), solvent system Hex:EtOAc (9:1) andDCM:MeOH (97:3) 
respectively. 
3.3.4 Tyrosinase enzyme Assay 
The screening of 25 plant extracts was studied for quantitative measurements by 
spectrophotometry method. Table 3.4 shows, the concentration at which 50 % of tyrosinase 
enzyme is inhibited (IC50) by the methanolic extracts. This study revealed that four plant extracts 
(16 %) such as Plectranthus ecklonii, P. madagascariensis, P. zuluensis and Salvia lanceolata 
inhibited tyrosinase strongly with IC50 values of < 30 𝜇g/mL, six plant extracts (24 %) inhibited 
tyrosinase moderately with IC50 values comprising between 30 and 100 𝜇g/mL while fifteen five 
plant species (60 %) inhibited tyrosinase poorly with IC50 values of >100 𝜇g/mL compared to the 
positive control (kojic acid IC50 = 3.42 𝜇g/mL). 
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Table 3.4: Screening of plant extracts for tyrosinase inhibitory activities  
Sample  IC50 (µg/mL) TLC- Bioautography (Rfvalue) 
Ballota africana > 500 - 
Leonotis leonurus > 500 - 
L. nepetifolia >500 - 
Mentha longifolia 212.46 - 
Plectranthus ambiguus 115.81 - 
P.ciliates 36.08 - 
P. ecklonii 21.58 0.43 
P. fruticosus 229.38 - 
P. grandidentatus 280.12 - 
P. hadiensis 36.08 - 
P. madagascariensis 23.99 - 
P. saccatus 38.49 - 
P. strigosus 45.74 - 
P. verticillatus 287.37 - 
P. zuluensis 23.99 0.42 
Salvia africana caerulea 81.98 - 
S. chamelaeagnea 267.4 0.38 ; 0.26 
S. disermas 226.96 - 
S. dolomitica 243.87 0.37 ; 0.2 
S. lanceolata 28.83 - 
S. muirii 103.73 - 
S. namaensis 301.86 0.4 
Stachys rugosa > 500 - 
Tetradenia riparia 171.39 - 
Thorncroftia succulenta 36.08 - 
Kojic acid 3.42 0.06 
*IC50 means the concentration of samples required for 50 % inhibition of tyrosinase activity .- : Not active 
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To summarize the outcome of the findings from the screening of plant materials for tyrosinase 
inhibitors using three complementary methods, cyclic voltammetry commonly used as suitable 
tool for detection of phenolic and antioxidant compounds through electrochemical measurement 
(Dobes, et al., 2013), was used for the first time for detection of tyrosinase inhibitors based on 
the behavior of each extracts toward tyrosinase and tyrosine by increasing or decreasing the 
inhibition current with time as controls. CVs developed nominated Leonotis leonurus, 
Plectranthus madagascariensis, P. saccatus, P. zuluensis P. saccatus, P. ecklonii, S. lanceolata, 
S. dolomitica and Salvia chamelaeagnea, as strong tyrosinase inhibitors due to the fact that they 
strongly decreased the inhibition current with time in the comparative manner with kojic acid. 
TLC bioautography, known as a quick and simple technique for screening of tyrosinase 
inhibitors (Wangthong, et al., 2007) was developed to detect extracts which have the potency to 
inhibit tyrosinase activity. Five extracts such as P. ecklonii, P. zuluensis, S. chamelaeagnea, S. 
dolimitica, and S. namaensis, demonstrated very clear white zone of inhibition on TLC plate. 
The appeared of white spots against a browning-purple background onto the TLC plate is an 
indication of the inhibition of the conversion of tyrosinase catalyzed by tyrosine to melanin 
(Misra & Dey, 2012). Spectrophotometric method nominated P. ecklonii, P. madagascariensis, 
P. zuluensis and S. lanceolata as strong tyrosinase inhibitors.  
These three complementary methods showed significant level of agreement as indicated, 
suggesting how reliable of the methods adopted by the investigation. For instance, P. zuluensis 
and P. ecklonii were identified by the three methods carried out, while two out of the three 
assays nominated P. madagascariensis, S. chamelaeaegnea, S. namaensis, S. lanceolata,and S. 
dolomitica as natural plants for anti-tyrosinase activities. 
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CHAPTER 4: ANTI-TYROSINASE AND TOTAL ANTIOXIDANT 
ACTIVITIES OF ISOLATED CONSTITUENTS OF SALVIA 
CHAMELAEAGNEA 
4.1 Introduction 
The preliminary phytochemical, bioautography, cyclic voltammetry and spectrophotometry 
screening of 25 plant species of Lamiaceae family carried out in Chapter 3 nominated S. 
chamelaeagnea as one of the most biologically active extract. However, the clear zone of 
inhibition in TLC-bioautography determined the final selection of this species. Thus, 
chromatographic isolation of compounds responsible for these biological profiles was carried out 
to elucidate their chemical structures and establish various biological specificity demonstrated by 
each compounds. 
4.2 Background information on Salvia chamelaeagnea 
Salvia chamelaeagnea (Lamiaceae; Salvia) is a flowering plant, commonly known as “sage”, a 
slow growing evergreen shrub growing up to 2 m with a spread of about 1 m originating from the 
South Western area of the Cape of Good Hope (Fig 4.1 B). In its natural habitat, S. 
chamelaeagnea develops into attractive foliage and flowering landscape plant, with small mid-
green egg shaped leaves and masses of bright blue or white flowers (Fig 4.1 A) (Kamatou, et al., 
2007). This plant has been used for medicinal purposes such as treating coughs and colds, colic 
and heartburn. History also documented that extract of this plant exhibit pharmaceutical effect 
against various microbial and bacterial infections (Kamatou, et al., 2008; Strelitzia, 2013) 
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Figure 4.1: Salvia chamelaeagnea description (A), and distribution along South Western area of 
the Cape of Good Hope. www.plantzafrica.com 
 
This chapter describes: 
 Isolation of the chemical constituents present in methanol extract of S. chamelaeagnea, 
using different chromatographic methods. 
 Elucidation of the chemical structure of each compound using different spectroscopic 
techniques. 
 Determination of tyrosinase inhibitory activity of the isolated compounds. 
 Evaluation of the total antioxidant capacities of isolated compounds. 
 Establishment of the relationship between the chemical structures of each constituents 
with the various biological behaviors through mechanism of reactions 
4.3 CHEMICAL CHARACTERIZATION OF SALVIA CHAMELAEAGNEA 
CONSTITUTUENTS 
4.3.1 Reagents and Solvents 
Organic solvents of methanol (HPLC graded), ethanol, ethyl acetate, dichloromethane, hexane 
(redistilled), deuterated chloroform was supplied by Merck (Darmstadt, Germany).  
A B 
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4.3.2 Chromatography 
4.3.2.1 Thin layer chromatography (TLC) 
Pre-coated plates of silica gel 60 F254 (Merck, Germany) was used for TLC analysis. 
Visualization of TLC plates was done by observing the bands “spots” after development under 
UV at wavelengths 254 and 366 nm using UV lamp (CAMAG, Switzerland), followed by 
vallinin/sulphuric acid spray reagent and then heated for phytochemical identification. Unless 
otherwise stated, the solvent systems generally used for the TLC development of S. 
chamelaeagnea fractions are indicated in Table 4.1 
Table 4.1: TLC solvent systems 
Solvent system Ratio Assigned code 
Hex - EtOAc 9:1 A 
Hex - EtOAc 7:3 B 
DCM - MeOH 9.5:0.5 C 
DCM - MeOH 9:1 D 
DCM - MeOH 7:3 E 
Hex: hexane; EtOAc: ethylacetate; DCM: dichloromethane; MeOH: methanol 
 
4.3.2.2 Column chromatography 
The column chromatography (different diameters) was performed using silica gel 60 H (0.040-
0.063 mm particle size, Merck, South Africa) and sephadex LH-20 (Sigma-Aldrich, South 
Africa) as stationary phases. 
4.3.2.3 Semi-preparative High Pressure Liquid Chromatography (HPLC) 
Final purification was carried out using Agilent Technologies 1200 series, equipped with UV 
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detector, manual injector, quaternary pump (G1311A), vacuum degasser (G1322A), column 
compartment (G1316A) and reversed phase C18 column SUPELCO (25 x 1.0 cm, 5 𝜇𝑚). The 
flow rate was set at 1.5 mL/min. All experiments were done at room temperature (20 o C). 
4.3.3. Nuclear magnetic resonance (NMR) spectroscopy 
NMR spectra were recorded at 20oC, using deuterated chloroform on a Bruker Avance 400 MHz 
NMR spectrometer (Germany), Chemical shifts of 1H (𝛿H) and 
13C (𝛿C) in ppm were determined 
relative to tetramethylsilane (TMS) as internal reference. 
4.4 Collection and identification of plant material 
The plant material used in this study was collected from the Cape Flats Nature Reserve as 
mentioned in chapter 3. 
4.5 Extraction and Fractionation of total extract 
The aerial parts of the fresh plant material (1.0887 Kg) were blended and extracted with 
methanol (4.5 L) at room temperature (25 oC) for 24 hours. The methanol extract was filtered 
and evaporated to dryness under reduced pressure at 40 oC to yield 29.55 g (2.71 %). The 
extracts were kept under cold conditions for further use. The total extract of S. chamelaeagnea 
(29 g) was applied to a silica gel column (30 x 18 cm) and eluted using gradient of hexane and 
ethyl acetate in order of increasing polarity as indicated in Table 4.2. Sixty four (64) fractions 
(500 mL each) were collected during the process and numbered 1-64. 
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Table 4.2: Fractionation of the extract of S. chamelaeagnea (SC) 
Solvent system Solvent volume Fraction collected 
Hexane 1L 1-2 
Hexane – ethyl acetate (95:5) 2L 3-6 
Hexane – ethyl acetate (90:10) 2L 7-10 
Hexane – ethyl acetate (85:15) 3L 11-16 
Hexane – ethyl acetate (80:20) 3L 17-22 
Hexane – ethyl acetate (75:25) 2L 23-26 
Hexane – ethyl acetate (70:30) 2L 27-30 
Hexane – ethyl acetate (60:40) 1L 31-32 
Hexane – ethyl acetate (50:50) 1L 33-34 
Hexane – ethyl acetate (40:60) 2L 34-37 
Hexane – ethyl acetate (30:70) 2L 38-41 
Hexane – ethyl acetate (20:80) 2L 42-45 
Hexane – ethyl acetate (10:90) 3L 46-51 
Hexane – ethyl acetate (5:95) 3L 52-57 
Ethyl acetate 3L 58-64 
 
The collected fractions (1-64) were concentrated and combined according to their TLC profiles 
(Fig 4.2) using solvent system (B &D) to yield 15 main fractions (Fig 4.3). The obtained 
fractions were coded by roman numbers (I - XV) and the results are summarized in table 4.3 
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Figure 4.2: TLC silica gel of the collected fractions of SC, solvent system Hex:EtOAc (7:3) and 
DCM:MeOH (9:1). 
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Table 4.3: Fractions obtained upon fractionation of total extract of S. chamelaeagnea 
Combined fraction Designated number Code Weight of fractions (mg) 
1-3 I SC-I 470.0 
4-5 II SC-II 366.0 
6-8 III SC-III 10.5 
9-12 IV SC-IV 305.0 
13-16 V SC-V 697.2 
17-18 VI SC-VI 620.1 
19-20 VII SC-VII 550.0 
21-29 VIII SC-VIII 1046.9 
30-32 IX SC-IX 1457.8 
33-34 X SC-X 465.2 
35-38 XI SC-XI 562.0 
39-44 XII SC-XII 1097.6 
45-46 XIII SC-XIII 116.0 
47-50 XIV SC-XIV 560.9 
51-64 XV SC-XV 503.8 
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  I    II   III  IV V VI VII VIII IX  X  XI XII   XIII XIV XV SC      I    II III  IV V VI VII VIII IX  X  XI XII   XIII XIV XV SC 
 
 
  I  II III  IV V VI VII VIII IX  X  XI XII XIII XIV XV SC  I II III  IV V VI VII VIII IX  X  XI  XII  XIII  XIV  XV SC 
 
Figure 4.3: TLC silica gel profile of combined fractions under UV (254 nm; A & B), and  
After spraying with H2SO4/ vanillin and then heated (C & D). 
TLC plate (A & C) of combined fractions (I-XV) was developed using solvent system D. 
TLC plate (B & D) of combined fractions (I-XV) was developed using solvent system C. 
 
4.6 Isolation of pure compounds 
4.6.1 Isolation of compound C1 – Column chromatography of main fraction SC-VII 
Main fraction SC-VII (550 mg) was chromatographed on sephadex column using isocratic 
elution of 5 % aqueous ethanol. Fractions of 5 mL each were collected and evaporated using 
A B 
C
  B 
D 
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rotary evaporator. Fractions obtained were developed on TLC using solvent system C and the 
fractions that displayed same profiles on the TLC plate were combined as indicated in Table 4.4. 
Table 4.4: Fractions grouped from the column 
Fraction Weight (mg) Assigned code 
5-9 33.2 SC-VII-1 
10-15 56.1 SC-VII-2 
16-20 69.2 SC-VII-3 
21-23 155.8 SC-VII-4 
24-31 195.2 SC-VII-5 
 
 
 
Figure 4.4: TLC silica gel of combined fractions of SC-VII, solvent system DCM:MeOH 
(9.5:0.5). 
 
Fractions 24-31 were suspected pure due to its single spot after development on TLC using 
solvent system C (Fig. 4.5). These fractions (24-31) were pooled together, evaporated and re-
spotted using solvent system C to further confirm the purity of the combined fractions. The TLC 
showed only single spot after development and confirmed the purity (Fig. 4.4) and labeled the 
compound as (C1, 195.2 mg, 0.67%). 
SC-VII 
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Figure 4.5 TLC silica gel of SC-VII-5 (C1), solvent system silica gel plate; solvent system 
DCM:MeOH (9.5:05). 
 
4.6.2 Isolation of compound C2 – Column chromatography of main fraction SC-VIII 
Main fraction SC-VIII (554 mg) was chromatographed on sephadex column using isocratic 
elution 5 % aqueous ethanol. Fractions of 5 mL each were collected and evaporated using rotary 
evaporator. Fractions obtained were developed on TLC using solvent system C and the fractions 
of same TLC profiles were combined as indicated in Table 4.5 
Table 4.5: Fractions grouped from the column 
Fraction Weight (mg) Assigned code 
1-7 10.7 SC-VIII-1 
8-13 29.1 SC-VIII-2 
14-21 179.6 SC-VIII-3 
22-23 84.8 SC-VIII-4 
24-32 
33-45                       
57.4 SC-VIII-5 
SC-VIII-6 
 
 
After spotting and developing the fractions on TLC plate using solvent system C, single spot was 
observed and suspected to be a pure compound as shown on the Figure 4.6. The fractions that 
50.1 
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gave the single spot (22-23) were combined together and labeled SC-VIII-4 (C2; 84.8 mg; 0.29 
%). 
 
Figure 4.6: TLC silica gel of combined fractions of SC-VIII, solvent system DCM:MeOH 
(9.5:05). 
 
4.6.3 Isolation of compound C3 Column chromatography of main fraction SC-VIII-6 
Injection of sub fraction SC-VIII-6 (50 mg) to the HPLC using gradient solvent system of MeOH 
and de-ionized water (75:25 to 100% MeOH in 40 min) afforded five (5) peaks (Figure 4.7). The 
prominent peak collected was labeled as SC-VIII-6-5 (C3, 28 min, 3.7 mg; 0.01 %).  
 
 
SC-VIII-4 
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Figure 4.7: HPLC chromatogram of C3. 
 
*Conditions 
Solvent MeOH:DIW 75:25 to 100% in 40 min 
Column SUPELCO, RP C-18 (25 x 1 cm) 
Flow rate 1.5 mL/min 
Detection UV at 254 nm 
 
4.6.4 Isolation of compound C4 Column chromatography of main fraction SC-VIII-2 
Injection of sub fraction SC-VIII-2 (629 mg) to the HPLC using gradient solvent system of 
MeOH and de-ionized water (75:25 to 100% MeOH in 40 min) afforded eighteen (18) peaks 
(Figure 4.8), the prominent peak collected and labeled as SC-VIII-2-17-A. After spotting and 
developing the fractions on TLC plate using solvent system C, a single spot suspected to be a 
pure compound was observed (Fig 4.11). The fraction that afforded this single spot were pooled 
together and labeled as SC-VIII-2-17-A (C4, 32.1 min, 13.79 mg; 0.04 %). 
 
 
SC-VIII-6-5 
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Figure 4.8: TLC silica gelof SC-VIII-2-17-A (Fig. 4.8 A), solvent system DCM:MeOH (9.5:0.5) 
and HPLC chromatogram of C4 (Fig. 4.8B). 
 
*Conditions 
Solvent MeOH:DIW 75:25 to 100% in 40 min 
Column SUPELCO, RP-18 (25 x 1 cm) 
Flow rate 1.5 mL/min 
Detection UV at 254 nm 
 
4.6.5 Isolation of compound C5 Column chromatography of main fraction SC-VIII-5 
Injection of sub fraction SC-VIII-5 (57.4 mg) to the HPLC and eluted using gradient solvent 
system of MeOH and de-ionized water (75:25 to 100% MeOH in 45 min) afforded eighteen (6) 
peaks (Figure 4.9), the prominent peak was collected and labeled as SC-VIII-5-1 (C5, 32.1 min, 
7.1 mg; 0.02 %). 
 
 
SC-VIII-2-17-A 
B A 
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Figure 4.9: HPLC chromatogram of C5. 
*Conditions 
Solvent MeOH:DIW 75:25 to 100% in 45 min 
Column SUPELCO, RP-18 (25 x 1 cm) 
Flow rate 1.5 mL/min 
Detection UV at 254 nm 
 
4.6.6 Isolation of compound C6 Column chromatography of main fraction SC-XIV 
Fraction XIV (500 mg) was chromatographed on sephadex column (5 % aqueous ethanol). 5 mL 
each of the fraction were collected, and evaporated using rotary evaporator. Fractions obtained 
were developed on TLC using solvent system D and fraction displayed same profiles on TLC 
were combined as indicated in Table 4.6 
 
Table 4.6: Fractions grouped from the column 
Fraction Weight (mg) Assigned code 
1-9 24.7 SC-XIV-1 
10-13 13.4 SC-XIV-2 
14-20 37.5 SC-XIV-3 
21-26 73.2 SC-XIV-4 
27-32 
     33-39            
 40-51     
52-64     
24.5 
37.4                                
17.8 
24.9 
SC-XIV-5 
SC-XIV-6 
SC-XIV-7 
SC-XIV-8 
 
 
 
SC-VIII-5-1 
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Figure 4.10: TLC silica gel of combined fractions of SC- XIV, solvent system DCM:MeOH 
(9:1). 
Sub fractionXIV-5 (24.5 mg) was injected to the HPLC and eluted using gradient solvent system 
of MeOH and de-ionized water (75:25 to 100% MeOH in 45min) which afforded a prominent 
peak in Figure 4.11, collected and labeled as SC-XIV-5-2. 
After spotting and developing the fractions on TLC plate using solvent system C, a single spot 
suspected to be a pure compound was observed (Fig 4.11). The fractions that afforded this single 
spot were pooled together and labeled as SC-XIV-5-2 (C6, 12.7 min, 13.6 mg, 0.04 %). 
SC-XIV-5 
 
 
 
 
http://etd.uwc.ac.za/
CHAPTER 4: ANTI-TYROSINASE AND TOTAL ANTIOXIDANT 
ACTIVITIES OF ISOLATED COMPOUNDS 
 
63 
 
 
Figure 4.11: TLC silica gel of SC-XIV-5-2 (Fig. 4.11 A, solvent system DCM:MeOH (9.5:05) 
and HPLC chromatogram of C6 (Fig. 11.B). 
*Conditions 
Solvent MeOH:DIW 75:25 to 100% in 45 min 
Column SUPELCO, RP-18 (25 x 1 cm) 
Flow rate 1.5 mL/min 
Detection UV at 254 nm 
 
 
 
 
 
 
 
 
 
 
 
 
A B 
SC-XIV-5-2 
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Salvia chamelaeagnea methanol extracts (SC) 
OPEN COLUMN (SILICA GEL) 
SC-VII SC-VIII SC-XIV 
                                                  SEPHADEX 
SC-VII-5 
Carnosol (C1) 
SC-VIII-4 
Carnosic acid (C2) 
 
SC-VIII-5  
SC-VIII-5-1 
Rosmanol (C5) 
 
SC-VIII-6 
HPLC FRACTIONATION   MeOH/DIW 
SC-VIII-6-5 
7- ethoxy-
rosmanol     (C3) 
SC-XIV-5 
SC-XIV-5-2 
Ladanein (C6) 
 
SC-VIII-2  
SC-VIII-2-17-A 
Ursolic acid (C4) 
 
Scheme 4.1: A flow diagram of experimental procedure for the isolation of compounds from S. 
chamelaeagnea 
*All silica gel column fractionations were done using gradient solvent system of Hex/EtOAc/MeOH. * All sephadex column fractionations were done using 
isocratic elution of aq. EtOH.  
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4.7 BIOLOGICAL CHARACTERIZATION OF ISOLATED COMPOUNDS 
4.7.1 General experimental procedure for biological assays 
4.7.1.1 Reagents  
Standards (purity > 99.0%) for the total antioxidant capacities (ORAC, FRAP & TEAC), 
inhibition of Fe2+-induced lipid peroxidation, and anti-tyrosinase assays such as kojic acid, 
EGCG (epigallocatechingallate), trolox (6-hydroxyl-2, 5, 7, 8- tetramethylchroman-2-carboxylic 
acid), and other reagents including ABTS (2,2- azino-bis (3-ethylbenzo thiazoline-6-sulfonic 
acid) diammonium salt), potassium peroxodisulphate, fluorescein sodium salt, AAPH (2,2-
Azobis (2-methylpropionamidine) dihydrochloride, perchloric acid, TPTZ (2,4,6-tri[2-pyridyl]-s-
triazine, iron (III) chloride hexahydrate, copper sulphate, hydrogen peroxide, were secured from 
Sigma-Aldrich, Inc. (Cape Town, South Africa). All antioxidant assays including FRAP, TEAC, 
lipid peroxidation, and tyrosinase inhibition were measured by Multiskan spectrum plate reader, 
while automated ORAC assay was determined using Floroskan spectrum plate reader. 
4.7.2 Tyrosinase enzyme assay 
This assay was performed using the method previously described (Chompo, et al., 2012) with 
slight modifications. Samples were dissolved in DMSO (dimethyl sulphoxide) to a stock solution 
of 1 mg/mL (w/v). Further dilutions were done with phosphate buffer (pH 6.5) for all working 
solutions to the concentrations of 1000, 500, 100, 50, 10 μg/mL. Kojic acid was used as a 
positive control. In each well of a 96-well plate, 70 μL of each sample working solution 
(extract/pure compounds) was combined with 30 μL of tyrosinase [from mushroom, 500 
Units/mL in phosphate buffer (pH 6.5)] in triplicate. After incubation at room temperature for 5 
minutes, 110 μL of substrate (2 mM L-tyrosine) was added to each well. The sample control was 
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made up of each sample with phosphate buffer in the absence of tyrosinase enzyme. The reacting 
mixture was then incubated for 30 minutes at room temperature. The enzyme activity was 
determined by measuring the absorbance at 490 nm using plate reader. The percentage of 
tyrosinase inhibition was calculated as follows. 
[(A – B) – (C – D)] / (A – B) X 100 (1) 
Where A is the absorbance of the control with the enzyme, B is the absorbance of the control 
without the enzyme, C is the absorbance of the test sample with the enzyme and D is the 
absorbance of the test sample without the enzyme. 
4.7.3 Cyclic voltammetry measurement 
Cyclic voltammetry was used for monitoring the oxidation-reduction potentials of the isolated 
compounds, and the behavior (increase or decrease) of the inhibition current with time in the 
presence of kojic acid or compound(s). 
It was performed using the BAS100B electro-chemical analyzer, a glassy carbon electrode 
(GCE) as working electrode, Ag/AgCl as a reference electrode and platinum (Pt) as a counter 
electrode. Cyclic voltammograms (CVs) were recorded at two different scan rates 50 mV/s and 
25 mV/s within the potential window ranging from -1300 to 1300 mV and from -200 to 200 mV. 
Both compounds and kojic acid were made to a stock solution of 1 mg/mL with DMSO. 
Tyrosinase and L-tyrosine were diluted in phosphate buffer to a working concentration and the 
experiments were carried out at room temperature. To a cell containing 10 mL of 50 mM PBS at 
pH 6.5, a fixed volume of compound and tyrosinase enzyme were added (700 𝜇L) and (300 𝜇L) 
respectively, to which a specific volume of the L-tyrosine (1100 𝜇L) was also added. To 
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understand the activity of the control either positive or negative, the compound was replaced 
with kojic acid and DMSO. Cyclic voltammetry of each addition was recorded. 
4.7.4 Total Antioxidant capacities assays 
4.7.4.1 Ferric-ion reducing antioxidant power (FRAP) assay 
The FRAP assay was carried out in accordance to the method described previously (Benzie & 
Strain, 1996). In a 96-well plate, 10 μL of the stock solution (1 mg/mL w/v) of the isolated 
compounds (C1 – C6) and a methanol extract (SC) were mixed with 300 μL FRAP reagent. The 
FRAP reagent was prepared by mixing (10:1:1, v/v/v) of acetate buffer (300 mM, pH 3.6), 
tripyridyl triazine (TPTZ) (10 mM in 40 mM HCl) and FeCl3.6H2O (20mM), Incubation 
commenced at room temperature for 30 min, and the plate was read at a wavelength of 593 nm in 
a Multiskan spectrum plate reader (Thermo Fisher Scientific). L-Ascorbic (Sigma Aldrich, South 
Africa) was used as a standard with concentrations varying between 0 and 1000 μM. Further 
dilutions were done to the samples that were highly concentrated and such dilution factors were 
recorded and used for calculations of the affected samples. The results were expressed as μM 
ascorbic acid equivalents per milligram dry weight (μM AAE/g) of the test samples. 
4.7.4.2 Automated oxygen radicals absorbance capacity (ORAC) assay 
ORAC assay was done according to the previous method (Prior, et al., 2003) with slight 
modifications (Cao & Prior, 1998). The method measures the antioxidant scavenging capacity of 
thermal decomposition generated by peroxyl radical of 2,2-azobis (2-amino-propane) 
dihydrochloride (AAPH) as peroxyradical (ORAC ROO
.) generator. The loss of fluorescence of 
fluorescein (probe) was an indication of the extent of its oxidation through reaction with the 
peroxyl radical. The protective effect of an antioxidant was measured by assessing the 
fluorescence area under the curve (AUC) plot relative to that of blank in which no antioxidant 
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was present. The analyzer was programmed to record the fluorescence of fluorescein every 2 
minutes after AAPH was added. The fluorescein solution and sample were added in the wells of 
an illuminated 96 well plate, 12 μL of each of sample (in stock solution of 1 mg/mL was 
combined with 138 μL of a fluorescein working solution followed by addition of 50 μL of 150 
mg of AAPH prepared in-situ in 6 mL phosphate buffer. Absorbance was measured with 
Fluoroskan spectrum plate reader with the excitation wavelength set as 485 nm and the emission 
wavelength at 530 nm. A calibration curve was used, using a trolox stock solution of 
concentration in the range of 83 - 417 μM (R2=0.9514). The ORAC values were calculated using 
a regression equation (Y = a + bX +Cx2) between Trolox concentration (Y in μM) and the net 
area under the fluorescence decay curve (X). ORAC values were expressed as micromoles of 
trolox equivalents (TE) per milligram of test sample. Samples without perfect curve were further 
diluted and the dilution factors were used for the calculation of such samples. 
4.7.4.3 Trolox equivalent absorbance capacity (TEAC) assay 
The total antioxidant activity of the test sample was measured using previously described 
methods (Pellegrini, et al., 1999). The stock solutions which contain 7 mM ABTS and 140 mM 
K2S2O8 was prepared and kept at -2 
oC. The working solution was then prepared by adding 88 μL 
K2S2O8 solution to 5 mL ABTS solution. The two solutions were mixed and allowed to react for 
24 hours at room temperature in the dark. Trolox was used as the standard with concentrations 
ranging between 0 and 500 μM. After 24 hours, the ABTS mix solution was diluted with ethanol 
to read a start-up absorbance (control) of approximately 2.0 (±0.1). The stock solution (1 
mg/mL) of a methanol extract (SC) and purified compounds (25 μL) were allowed to react with 
300 μL ABTS in the dark at room temperature for 30 min. The absorbance was read at 734 nm at 
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25 oC in the plate reader. The results were expressed as μM trolox equivalents per milligram dry 
weight (μM/TE/g) of the test samples. 
4.7.4.4 Inhibition of Fe (II) - Induced Microsomal Lipid Peroxidation assay 
A method described by (Snijman, et al., 2009)with a few modifications was adopted. The 
reaction mixture contained microsomes (1mg of protein/mL in 0.01 M potassium phosphate 
buffer; pH 7.4, supplemented with 1.15 % KCl). The positive control includes microsomes, 
buffer and ferrous sulphate, in the absence of the samples to be tested. 
The sample stock solutions (SC and C1-C6) were prepared in DMSO (1mg/mL, w/v). The 
working sample solutions were prepared in 0.01 M potassium phosphate buffer pH 7.4, 
supplemented with 1.15 % KCl diluted to100, 50 and 10 μg/mL concentrations. 100 μL of each 
sample (working solutions) were dissolved in potassium phosphate buffer and pre-incubated with 
500 μL microsomes a 37 oC for 30 minutes in a shaking water bath. 200 μL of KCl-buffer were 
added to the mixture, followed by 200 μL of a 2.5 mM ferrous sulfate solution and incubated at 
37 oC for 1 hour in a shaking water bath. The reaction was terminated with 10 % trichloroacetic 
acid (TCA) solution (1 mL) containing 125 μL butylated hydroxytoluene (BHT, 0.01 %) and 1 
mM ethylene diamine tetra acetic acid (EDTA). Samples were centrifuged at 2000 rpm for 15 
minutes, and 1 mL of each supernatant was mixed with 1 mL of 0.67 % thiobarbituric acid 
(TBA) solution. The reaction mixture was then incubated in a water bath at 90 oC for 20 minutes 
and the absorbance were measured at 532 nm using plate reader. The percentage inhibition of 
TBARS formation relative to the positive control was calculated by  
[(Acontrol – Asample)/ Acontrol X 100)] (2) 
 
 
 
 
http://etd.uwc.ac.za/
CHAPTER 4: ANTI-TYROSINASE AND TOTAL ANTIOXIDANT 
ACTIVITIES OF ISOLATED COMPOUNDS 
 
70 
 
4.8 Chemical characterization: Results and discussion 
4.8.1 Structure elucidation of carnosol (C1) 
Compound 1 (195.2 mg) (Fig. 4.12) was isolated as described in Scheme 4.1 and obtained as a 
white crystal. It was identified as carnosol based on its NMR data. 1H-NMR showed singlets of 
two methyls at H 0.75, and 0.72 (Me-18, 19) and two doublets counted for six protons at 1.06 
and 1.05 (Me-16, and 17); septet at 3.36, (H-15), a low field shift proton at 5.26 dd (H-7), a 
singlet at 6.51 for the aromatic proton H-14. The 13C-NMR showed 20 carbons, which confirmed 
the diterpene skeleton. DEPT-135 and HSQC split those carbons into 4 methyls (22.4 X 2/C16, 
17; 31.4/18 and 19.3/19); four methylene (28.6/C1; 18.6/C2; 40.7/C3; 29.5/C6);  four methines; 
one of them aromatic (111.6/C14); one hydroxylated (78.1/C7); in addition the five signals of 5 
aromatic carbons ( 131.6/C8; 121.5/C9; 142.4/C11; 142.3/C12; 134.2/C13) and a carbonyl group 
(177.5). The HMBC showed cross peaks (among others) of H14 with C15; C7; C9; C11 and/or 
C12, H7/C5; C6; C14; C9; C8; C20; C12, H15/C16,17; C14; C13; C11 and C12. The above data 
with 2D NMR experiments (HSQC, HMC, and COSY) established the structure of carnosol (1) 
and finally confirmed by comparing the experimental data with literature (Inatani et al., 1982). 
Carnosol was first isolated from Salvia carnosa in 1942 and its chemical structure was first 
established in 1964 (Brieskorn, et al., 1964) and widely distributed within the family members of 
lamiaceae most especially Salvia and Rosemary. 
OH
O
O
HO
 
Figure 4.12: Chemical structure of carnosol 
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Figure: 4.13: 1H NMR spectrum of compound 1  
 
Figure: 4.14: 13C NMR spectrum of compound 1 
OH
O
O
HO
 
OH
O
O
HO
 
 
 
 
 
http://etd.uwc.ac.za/
CHAPTER 4: ANTI-TYROSINASE AND TOTAL ANTIOXIDANT 
ACTIVITIES OF ISOLATED COMPOUNDS 
 
72 
 
 
Figure 4.15: DEPT NMR spectrum of compound 1 
 
Figure 4.16: HMBC NMR spectrum of compound 1 
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Figure 4.17: HMQC NMR spectrum of compound 1 
 
Figure 4.18: COSY NMR spectrum of compound 1 
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4.8.2 Structure elucidation of carnosic acid (C2) 
Compound 2 (84.8 mg) (Fig. 4.13) was isolated as described in Scheme 4.1 and obtained as 
amorphous powder. It was identified as carnosic acid from its NMR data. NMR data was similar 
to that of compound 1 except the absence of the signal at 5.58. The carbon signals showed five 
methylene (extra one than 1) and three methines (less one than 1). The 13C signal of the carbonyl 
carbon was shifted to a lower field (182.1) which indicate free carboxyl group. The above data 
with comparison of the obtained data with literature confirmed the structure of compound 2 as 
carnosic acid. Many literatures (Topcu, et al., 2013) described the isolation of carnosic acid as its 
methyl ester derivative due to the fact that, the free carboxyl group makes the chromatographic 
separation very difficult and also contribute to the instability of the compound during the 
separation process. 
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Figure 4.19: Chemical structure of carnosic acid 
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Figure 4.20: 1H NMR spectrum of compound 2 
 
Figure 4.21: 13C NMR spectrum of compound 2 
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Figure 4.22: DEPT NMR spectrum of compound 2 
 
Figure 4.23: HMQC spectrum of compound 2 
OH
HO
HOOC
 
OH
HO
HOOC
 
 
 
 
 
http://etd.uwc.ac.za/
CHAPTER 4: ANTI-TYROSINASE AND TOTAL ANTIOXIDANT 
ACTIVITIES OF ISOLATED COMPOUNDS 
 
77 
 
 
Figure 4.24: COSY spectrum of compound 2 
 
 
 
 
 
 
OH
HO
HOOC
 
 
 
 
 
http://etd.uwc.ac.za/
CHAPTER 4: ANTI-TYROSINASE AND TOTAL ANTIOXIDANT 
ACTIVITIES OF ISOLATED COMPOUNDS 
 
78 
 
4.8.5 Structure elucidation of rosmanol (C5) 
Compound 5 (7.1 mg) (Fig. 4.16) was isolated as described in Scheme 4.1 and obtained as brown 
amorphous solid. The NMR data of C5 showed a typical abietane diterpene skeleton and similar 
to compound 1 and 2. 1H NMR showed two doublet signals at 4.49 (d, J6.7 = 2.3; H-6); 4.66 d 
(J6.7 = 2.3 H-7) 6.80 s (H-14); 3.07 Septet (J15.6/7 = 6.8; H-15); 3.11 (m, H-1 in add to four 
methyl signals, two of them appeared as doublets at 1.19; 1.18 (Me-16; 17; J = 6.8 Hz); and the 
other two as singlets at 0.88 (Me-18) and 0.87 (Me-19). The 13C-NMR and DEPT-135 showed 
20 carbons, four of them are methyls at 22.1/C16 (or C17); 22.6/C17 (or C16); 32.0/C18 and 
20.0/C19, three methylene signals at 27.3; 19.1 and 38.2 (C1-C3 respectively); five methines, 
two of them are oxygenated at 78.2/C6 and 68.5/C-7 and one aromatic at 120.3/C-14, the other 
two methines attributed to C5 (50.8) and C15/27.3. In addition to seven quaternary carbons, five 
of them belong to the aromatic ring (128.1, 124.5, 142.9, 141.8, 135.1 (C8, C9, C11-C13 
respectively) and a carbonyl group at 178.9 (C-20); the other two belong to C-10 and C-4 (at 
47.2 and 31.3). The chemical shift of C-20 appeared at higher field than compound 2 which 
indicated the formation of lactone ring also, the H-6 only coupled with H-7 but not with H-5, 
which indicate the 90o coplanar of H-5 and H-6 and confirm the lactonization at C-6. Finally, the 
NMR data of rosmanol was identical with those published in literature (Inatani et al., 1982) and 
established the structure of compound 5 as rosmanol. 
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Figure 4.25: Chemical structure of rosmanol 
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Figure 4.26: 1H NMR spectrum of compound 5 
 
Figure 4.27: 13C NMR spectrum of compound 5 
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Figure 4.28: DEPT spectrum of compound 5 
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4.8.3 Structure elucidation of 7-ethoxyrosmanol (C3) 
Compound 3 (3.7 mg) (Fig. 4.14) was isolated as described in Scheme 4.1 and obtained as a 
yellow amorphous powder. It was identified as 7-ethoxyrosmanol based on its NMR data. It 
showed identical signal with that of compound 3 except the chemical shift of C-7 and the 
presence of ethoxy group in compound 3 (13C, 66.4 t; 1H, 16.2 q) indicated that 7-ethoxy 
derivative of 3. This was confirmed by comparison of the obtained NMR data with those 
published in literature (Arisawa, et al., 1987).  
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Figure 4.29: Chemical structure of 7-ethoxyrosmanol 
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Figure 4.30: 1H NMR spectrum of compound 3
 
Figure 4.31: 13C NMR spectrum of compound 3 
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4.8.4 Structure elucidation of ursolic acid (C4) 
Compound 4 (13.79 mg) (Fig. 4.15) was isolated as described in Scheme 4.1 and obtained as 
white powder. It was identified as ursolic acid based on its NMR data, which showed typical 
triterpene signals with 3 𝛽-OH; carboxylic group (C-28) and C12-13 double bond. The identity of 
the compound confirmed by comparing the experimental data with literature (Guvenalp, et al., 
2006). Ursolic acid is a well-known triterpene and widely distributed in plants, the same 
compound was identified previously from Leonurus cardiac (Ali, et al., 2007). 
 
Figure 4.32: Chemical structure of ursolic acid 
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Figure 4.33: 1H NMR spectrum of compound 4 
 
Figure 4.34: 13C NMR spectrum of compound 4 
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Figure 4.35: 1H NMR spectrum of compound 4 
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4.8.6 Structure elucidation of ladanein (C6) 
Compound 6 (13.6 mg) (Fig. 4.15) was isolated as described in Scheme 4.1 and obtained as 
yellow amorphous solid. The compound showed 15 carbons in addition to two O-Me signals at 
(δH/ δC); 3.87/55.6 and 3.98/56.76. The 15 carbons of the main skeleton indicated Flavonoid type 
of Apigenin nucleus. The compound showed in NMR signals at 12.57 attributed to 5-OH, and 
showed cross-peaks in HMBC with C10 (105.9); C5 (145.9) and C6 (129.5). The singlet signal at 
6.56 (counted 2H) attributed to H-3 and H-8; it showed HMBC correlations with C9, C10, C7, C6, 
[H8] and C2; C4; C10; C1 [H-3]. The positions of the two OMe were established by HMBC. The 
NMR data of ladanein was identical with those published in literature (Farjam, et al., 2013) and 
other 2-D NMR correlations confirm the structure of compound 6as 6–hydroxy-7,4`-
dimethoxyapigenin (ladanein). 
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Figure 4.36: Chemical structure of Ladanein 
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Figure 4.37: 1H NMR spectrum of compound 6 
 
Figure 4.38: 13C NMR spectrum of compound 6 
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Figure 4.39: DEPT spectrum of compound 6 
 
Figure 4.40: HMBC spectrum of compound 6 
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Figure 4.41: HMQC spectrum of compound 6 
 
Figure 4.42: COSY spectrum of compound 6 
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Table 4.7: 13C NMR data of C1, C2, C3 and C5 compared to the NMR data from the literature 
  Carnosol Carnsoic acid rosmanol 7-ethoxy rosmanol 
Exp.* Reported** Exp.* Exp.* Reported** Exp.* Reported** 
C C C C C C C 
1.  28.6 29.8 t 34.4 27.3 t 28.4 t 27.4 t 28.3 t 
2.  18.6 19.7 t 20.3 19.1 t 19.9 t 19.0 t 19.8 t 
3.  40.7 41.9 t 41.6 38.2 t 39.1 t 38.0 t 38.9 t 
4.  34.2 35.1 s 34.5 s 31.3 s 32.0 s 31.4 s 32.0 s 
5.  45.3 46.4 d 53.9 d 50.8 d 51.0 d 50.9 d 51.5 d 
6.  29.5 30.6 t 18.9 78.2 d 78.8 d 75.3 d 75.4 d 
7.  78.1 78.2 d 31.5 68.5 d 69.1 d 75.7 d 76.8 d 
8.  131.6 133.6 s 129.0 128.1 s 130.4 s 126.6 s 128.4 s 
9.  121.5 123.1 s 122.6 124.5 s 124.9 s 124.6 s 124.1 s 
10.  48.2 49.2 s 48.7 s 47.2 s 47.7 s 47.0 s 47.6 s 
11.  142.3 143.8 s 142.3 142.9 s 144.7 s 142.7 s 144.6 s 
12.  142.4 143.4 s 141.2 141.8 s 142.5 s 141.4 s 142.6 s 
13.  134.2 135.1 s 133.6 135.1 136.5 s 134.6 s 136.3 s 
14.  111.6 112.4 d 119.1 d 120.3  120.2 d 120.8 d 120.6 d 
15.  26.6 27.6 d 27.0 d 27.3 27.5 d 27.2 d 27.4 d 
16.  22.4 23.0 q 22.5 q 22.1 q 22.9 q 22.2 q 22.9 q 
17.  22.4 23.1 q 22.1 q 22.6 q 23.1 q 22.3 q 23.1 q 
18.  31.4 32.0 q 32.6 q 31.4 q 31.8 q 31.3 q 31.8 q 
19.  19.3 20.0 q 21.5 q 22.3 q 22.4 q 22.0 q 22.3 q  
20.  177.5 175.9 s 182.1 178.9 s 178.3 s 179.1 s 178.4 s 
-CH2 CH3      66.2 t 66.4 t 
CH2 CH3      15.8 q 16.2 q 
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Table 4.8: 1HNMR data of C1, C2, C3 and C5 compared to the NMR data from the literature 
  
Carnosol  
OH
O
O
HO
1
4 7
11 13
16(17)
17(16)
15
18 19
20
 
Carnosic acid
OH
HO
HOOC
 
 
Rosmanol  
7-ethoxy-
rosmanol  
 Exp.* Reported*
* 
Exp.* Exp.* Reported
** 
Exp.* Reported
** 
H-1 2.36 ddd, 13.8, 4.4, 4.4 2.55 ddd 1.17
#
 1.94 ddd, 
13.5, 5.0, 5.0 
1.98 ddd 1.96 ddd, 
14.0, 5.6, 5.6 
1.96 m 
H-1 2.71 dddd, 13.8, 13.8, 
4.4, 3.3 
2.82 dddd 3.26 br. d. 
14.4  
3.11 brd, 16.0 3.29 m 3.31 brd, 14.0 3.30 m 
H-2 1.51 ddddd, 13.8, 3.9, 
3.9, 3.9, 3.9 
1.57 
ddddd 
1.73 br.d. 14.3 1.46 m 1.59 
dddd 
1.64 m  
H-2 1.81 ddddd, 13.8, 13.8, 
13.8, 3.9, 3.9 
1.93 dddd 1.56 m 1.39 m 1.47 
dddd 
1.40 m  
H-3 1.39 ddd, 13.9, 3.9, 3.9 1.31 ddd 1.29 ddd 13.7, 
3.4, 3.4 
1.10 brd, 13.5 1.27 ddd 1.09 m  
H-3 1.13 ddd, 13.9, 13.9, 
3.9 
1.50 dddd 1.44 br.d 13.1 1.37 m 1.44 ddd 1.53 m  
H-5 1.60 dd, 10.6, 5.4 1.70 dd 1.53 br.d 13.1 2.15 s 2.29 s 2.26 s 2.22 s 
H-6 2.06 ddd, 13.4, 5.4, 4.0 2.19 ddd 2.37 m 4.49 d, 2.3 4.52 d 4.34 d 3.1  4.35 d 
H-6 1.75 dddd, 13.4, 10.6, 
4.0, 1.4 
1.85 ddd 1.82 m ---- --   
H-7 5.26 dd, 2.0, 5.0 5.43 dd 2.79 m 4.66 d, 2.3 4.64 d 4.63 d 3.1 4.75 d 
H-7   2.79 m     
H-14 6.51 s 6.77 s 6.53 s 6.80 s 6.89 s 6.77 s 6.84 s 
H-15 3.07 sept, 7.0 3.36 sept 3.14 sept 6.0 3.07 sept, 6.8 3.27 sept 3.05 sept, 6.8 3.27 m 
H-16(Me) 1.06 d, 1.5 1.18 d 1.17 d 6.0 1.16 d, 6.8 1.17 d 1.20 d, 6.8 1.17 d 
H-17(Me) 1.05 d, 1.5 1.19 d 1.17 d 6.0 1.13 d, 6.8 1.18 d 1.20 d, 6.8 1.20 d 
H-18(Me) 0.75 s 0.88 s 0.97 s 0.95 s 1.02 s 0.99 s 1.02 s 
H-19(Me) 0.72 s 0.87 s 0.87 s 0.85 s 0.90 0.91 s 0.91 s 
-CH2 CH3      3.83 m  
CH2 CH3      1.31, 7.0  
* in CDCl3 
**in Acetone – d6 (see Inatani et. al. 1982 and Arisawa et. al. 1987)   
 
 
 
 
 
 
 
OH
O
O
HO
OH
OH
O
O
HO
OC2H5
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4.9 Biological evaluations: Results and discussion 
In this study, an in vitro investigation were carried out to determine the anti-tyrosinase activity 
and the total antioxidant capacities of a methanol extract of S. chamelaeagnea and its 6 isolated 
constituents (C1-C6). Spectrophotometry and cyclic voltammetry assays were carried out for the 
evaluation of tyrosinase inhibitory activities with kojic acid as a positive control, while the 
FRAP, TEAC, ORAC and Fe2+- induced lipid peroxidation assays were used to evaluate the 
antioxidant and oxidative damage modulatory capacities of the extract and isolated compounds 
while, trolox, ascorbic acid and EGCG were used as reference. 
4.9.1 Evaluating the anti-tyrosinase activity of the isolated compounds 
The methanolic extract (SC) and the isolated compounds (C1-C6) were evaluated for their 
tyrosinase inhibitory activity at different concentration as illustrated in Table 4.9. The result 
revealed that C1 demonstrated the highest tyrosinase inhibitory activity (IC50 = 455.5 μg/mL) 
among the isolated compounds tested. Recently, tyrosinase inhibitors have received great 
attention, due to its alleviating properties to deliver skin lightening and anti-aging benefits, 
caused by undesirable skin hyperpigmentation (Narayanaswamy, et al., 2011). The results 
showed anti-tyrosinase activity in order of C1>C3>C4>C2>C6>C5 as illustrated in Table 4.9. 
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Table 4.9: Percentage of tyrosinase inhibition and IC50 of S. chamelaeagnea constituents 
% inhibition (μg/mL) 
Sample 1000  500  100  50  10  IC50 
C1 99.30 67.44 9.71 4.89 4.19 455.5 
C2 91.69 55.4 10.49 4.19 3.88 514.9 
C3 / 53.72 11.22 2.94 -5.1 465.7 
C4 97.12 54.39 11.96 10.25 2.09 485.2 
C5 / 42.28 1.7 -4.48 -1.31 >500 
C6 99.77 29.33 9.52 4.87 4.50 554.5 
SC 94.79 58.73 51.54 44.56 20.25 267.4 
KA 98.88 98.50 98.42 98.12 67.74 3.4 
KA: kojic acid;SC: methanol extract of S. chamelaeagnea; C1-C6: Isolated compounds (1-6) 
 
C1 C2 C3 C4 C6 SC KA
0
100
200
300
400
500
 
 
IC
50
 (µ
g/m
L)
Samples
 
KA>SC>C1>C3>C4>C2>C6 
Figure 4.43: Effects of S. chamelaeagnea constituents on inhibition of tyrosinase enzyme 
*Data are expressed as IC50 with all samples screened at 1000μg/mL  
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4.9.2 Cyclic voltammetry (CV) measurement 
4.9.2.1 Cyclic voltammetry measurement of redox peaks of isolated compounds 
CV is the most common reliable technique used for the characterization of redox system. It gives 
information about the number of redox states as well as qualitative information about the 
stability of these oxidation states and the electron transfer kinetics (Sochor, et al., 2013). 
CV on glassy carbon electrode recorded for monitoring the oxidation-reduction potentials of 
isolated compounds (C1-C6) and extract at the broad scan range from -1300 to 1300 mV at 50 
mV/s indicated all the compounds except C4 are electro-active with well-defined oxidation-
reduction peaks. The electro-activity of these compounds are illustrated by the fact that redox 
peaks are shown on Figure 4.35, an indication that the compounds possessed hydroxyl groups 
which are susceptible to be oxidized to their corresponding quinone, and reduced back to the 
initial compound. This electro-oxidation can be attributed to the electron transfer reaction 
involving to the oxidized product. Therefore, CV is a suitable method for the detection of 
phenolic compounds (Magarelli, et al., 2013). It has been reported that compound with the ability 
to be oxidized more easily appear to be in higher amount as antioxidant capacity is more 
extensive (Dobes, et al., 2013). There is a relationship between electrochemical behavior of 
compounds with antioxidant activity and their resulting antioxidant power capacity, and it is 
known that low oxidation potential corresponds to the high antioxidant power (Sochor, et al., 
2013). C1 demonstrated the highest electron transfer capacity with the highest anodic peak 
current value (0.7 µA), which is in agreement with TEAC (16505.0 ± 0.86 µM TE/g) and FRAP 
(9338.92 ± 1.72 µM AAE/g). The mechanism of these two antioxidant assays (FRAP & TEAC) 
are measure of electron transfer as well as that of CV. The results obtained therefore are in 
agreement with C1 demonstrated highest values for the 3 assays that measure electron transfer 
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mechanism. This electron transfer property may be attributed to the presence of an ortho-
dihydroxy group on the C-ring of C1 (Miura, et al., 2002). Table 4.10 showed the anodic peak 
current and potential of the tested samples.  
Table 4.10: Anodic peak current of S. chamelaeagnea constituents 
Sample ipa/µA Epa/V 
C1 0.70 0.16 
C2 0.33 0.15 
C3 0.18 0.33 
C4 / / 
C5 0.260 0.11 
C6 0.60 0.16 
SC 0.14 0.157 
SC: methanol extract of S. chamelaeagnea; C1-C6: Isolated compounds (1-6) 
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Figure 4.44: CVs recorded at 50 mV/ s in broad scan range from -1300 to 1300 mV for 1 mg/L of each 
compounds in phosphate buffer (pH 6.5).  
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4.9.2.2 Cyclic voltammetry measurement of tyrosinase inhibitory activity 
The tyrosinase inhibitory activity of the isolated compounds (C1-C6) was investigated using CV 
by direct measurement of the inhibition current with time at the scan range (from -200 to 200 
mV). The result indicated C1 demonstrated the strongest tyrosinase inhibitory activity by 
decreasing the inhibition current with time in comparison to kojic acid, indicating that the 
inhibitory activity demonstrated by kojic acid is 1.5 times more active than C1. Among the 
tested compounds, only C4 increased the inhibition current with time as shown in Table 4.11 and 
Figure 4.45, 4.46. According to the result, C1 demonstrated the highest anti-tyrosinase activity 
among the tested compound by strongly decreased the inhibition current with time as kojic acid. 
Table 4.11: Inhibition current in the presence of the compounds, positive and negative controls 0 
and 30 min after addition of tyrosinase and tyrosine based on the anodic process at 131 mV from 
the corresponding CVs 
Sample iinh/ 10
-2µA at 0 min iinh/ 10
-2µA at 30 min 
C1 11.5 2.7 
C2 16.8 8.1 
C3 10.3 5.4 
C4 3.1 6.2 
C5 12.2 6.9 
C6 14.5 11.1 
SC 3.4 2.5 
PC 2.1 1.8 
NC 2.08 80.9 
PC: positive control; NC: negative control; SC: methanol extract of S. chamelaeagnea; C1-C6: Isolated compounds (1-6) 
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Figure 4.45: CVs recorded at 25 mV/ s in wide scan range from -200 to 200 mV for each 
isolated compounds in PBS for the reaction mixture of tyrosine and tyrosinase in 50 mM PBS 
(pH 6.5) at different times.  
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Figure 4.46: Effect of S. chamelaeagnea constituents on inhibition of tyrosinase activity 
 
To evaluate the amenability of the method adopted, the enzyme activity was determined by 
measuring the inhibition based on charge of each isolated compounds and controls. The 
percentage of inhibition was calculated as follows. 
[(Q30' – Q0')/ Q0'] X 100 (2) 
Where  Q30' is the inhibition based on charge at 30 min, Q0' is the inhibition based on charge at 0 
min. 
The result presented in Table 4.12 is an indication about the percentage of inhibition of each 
compound. According to the obtained result, all the tested compounds except C4 demonstrated 
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some activity by decreasing the inhibition based on charge with time and C1 showed the highest 
percentage of inhibition amongst the tested compounds by strongly decreased the inhibition 
current based on charge with time.  
Table 4.12: Inhibition based on charge of the compounds, positive and negative controls at 0 and 
30 min in the presence of tyrosinase and tyrosine obtained by integrating the anodic area from 
the corresponding CVs 
 
Abg A0' A30' Qbg Q0' Q30' Q30'-Q0' 
 
 
Area 
before 0 
min/10
-4
 
Area at 
0 
min/10
-4
 
Area at 30 
min/10
-4
 
Qbg/ mC Q0min/ mC 
Q30min/ 
mC DQ/ mC %DQref 
C1 30.07 21.19 4.71 120.28 84.76 18.84 -65.92 113.4 
C2 30.35 25.51 12.8 121.4 102.04 51.2 -50.84 110.4 
C3 18.9 15.6 8.99 75.6 62.4 35.96 -26.44 105.4 
C4 7.4 7 10.95 29.6 28 43.8 15.8 96.8 
C5 19.5 17.1 11.56 78 68.4 46.24 -22.16 104.5 
C6 27.7 25.5 22.6 110.8 102 90.4 -11.6 102.4 
SC 8.03 4.18 1.65 32.12 16.72 6.6 -10.12 102.1 
PC 4.8 4.9 4.24 19.2 19.6 16.96 -2.64 100.5 
NC 3 4.2 12.42 12 16.8 49.68 32.88 0.0 
PC: positive control; NC: negative control; SC: methanol extract of S. chamelaeagnea; C1-C6: Isolated compounds (1-6) 
 
4.9.3 Evaluating the FRAP and TEAC activity of the isolated compounds 
The TEAC is based on single electron transfer (SET) mechanism in which the antioxidant (test 
samples) donates an electron to the corresponding cationic radical to neutralize it (Pérez-Fons, et 
al., 2010). The FRAP assay measures the sample’s capacity to reduce the intense color of blue 
ferric TPTZ complex to its ferrous form in acidic medium (Fe3+ to Fe2+), thereby changing its 
absorbance (Firuzi, et al., 2005). The results showed that C1 and C5 (9338.92 ± 1.72; 8622.73 ± 
1.92) µM AAE/g respectively demonstrated excellent activity on FRAP when compared to the 
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commercial antioxidant EGCG (4722.51 ± 2.22) µM AAE/gas illustrated in Table 4.13. On the 
other hand, C1 and C5 (16505.5 ± 0.86; 10641.5 ± 0.52) µM TE/g respectively also 
demonstrated the highest TEAC value when compared to EGCG (10455 ± 0.81) µM TE/g.  
The excellent activity demonstrated by C1 and C5 is due to the presence of an ortho-dihydroxy 
group on the C-ring which has the radical scavenging property by transferring electron to the 
corresponding free radicals (Miura, et al., 2002). In general, phenolic compounds can easily 
transfer or donate electrons to the reactive radicals because of the resonance stability of phenoxy 
radical and this induced radical chain reactions delay. The obtained phenoxy radical is less active 
than the initial one (Özgen, et al., 2011). 
Table 4.13: FRAP and TEAC antioxidant capacities of S. chamelaeagnea constituents 
Sample FRAP (µM AAE/g) TEAC (µM TE/g) 
C1 9338.92 ± 1.72 16505.5 ± 0.86 
C2 
C3 
4695.98 ± 2.59 
1113.05 ± 5.6 
5897.5 ± 1.03 
4618.2 ± 1.11 
C4 
C5 
117.26 ± 2.6 
8622.73 ± 1.92 
-57 ± 1.62 
10641.5 ± 0.52 
C6 5027.55 ± 4.62 8296.2 ± 1.18 
SC 9869.43 ± 7.87 13706.5 ± 0.95 
EGCG 4722.51 ± 2.22 10455.1 ± 0.81 
EGCG: Epigallocacatechingallate; SC: methanol extract of S. chamelaeagnea; C1-C6: Isolated compounds (1-6) 
4.9.4 Evaluating the ORAC activities of the isolated compounds 
Results obtained from the investigation of the oxygen radical antioxidant capacity revealed that 
C1 and C5 demonstrated significant ORAC value (14550.5 ± 3.65; 14633.90 ± 3.84) µMTE/g in 
a competitive manner to that of EGCG (14970 ± 5.53 µMTE/g) as shown in Table 4.14.The 
findings showed activity in order of C5>C1>C2>C6>C3>C4. Therefore, the activity of  C1 and 
 
 
 
 
http://etd.uwc.ac.za/
CHAPTER 4: ANTI-TYROSINASE AND TOTAL ANTIOXIDANT 
ACTIVITIES OF ISOLATED COMPOUNDS 
 
102 
 
C2 is related to the fact that they have a single aromatic ring, hydroxylated by 2 OH groups, 
which serve as hydrogen donating agent to peroxyl radicals thereby stabilizing them and giving 
rise to a relatively stable radical (Özgen, et al., 2011).  
Table 4.14: Oxygen radical’s antioxidant capacity of S. chamelaeagnea constituents 
Sample Automated oxygen radical  
Absorbance  capacity (ORAC µMTE/g) 
 
C1 
 
14550.50 ± 3.65 
C2 
C3 
10398 ± 1.81 
8247.35 ± 6.83 
C4 
C5 
2080.19 ± 8.52 
14633.90 ± 3.84 
C6 8380.08 ± 4.52 
SC 14338.49 ± 5.16 
EGCG 14970 ± 5.53 
EGCG: Epigallocacatechingallate; SC: methanol extract of S. chamelaeagnea; C1-C6: Isolated compounds (1-6) 
4.9.5 Evaluating the Fe2+-induced anti-lipid peroxidation activity of the isolated compounds 
Lipid peroxidation is a process whereby polyunsaturated lipids of the membranes are susceptible 
to oxidative damage via the reaction attack of free radical. It is one of the consequences of 
oxidative stress (Ayala, et al., 2014).  
The results showed that C5 and C1 in comparison with (EGCG) display excellent inhibitory 
activity against Fe2+-induced anti-lipid peroxidation (IC50 = 30.25; 32.5; 41.50) µg/mL 
respectively, followed by C2 (IC50 = 38.5 µg/mL) as shown in Table 4.15. Their significant 
activity recorded were due to the presence of vicinal –OH groups in C1 and C2 that can chelate 
with pro-oxidative metalsor scavenge peroxyl radical thereby preventing oxidation. However, the 
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unreactivity of C4 in lipid peroxidation may be explained by the lack of a phenolic moiety 
(Özgen, et al., 2011).  
 
Table 4.15: Lipid peroxidation of S. chamelaeagnea constituents 
Sample 100 μg/mL 50 μg/mL 10 μg/mL IC50 
C1 82.2 81.05 24.66 32.5 
C2 
C3 
81.28 
19.86 
78.31 
20.54 
20.11 
11.54 
38.35 
>100 
C4 
C5 
17.77 
82.01 
14.58 
79.71 
11.12 
27.94 
>100 
30.25 
C6 36.93 51.94 20.41 >100 
SC 43.98 22.11 10.26 >100 
EGCG 91.31 43.19 37.48 41.50 
Data are given as IC50 with tested sample screened at 100 μg/mL; SC methanolic extract 
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Figure 4.47: Effects of S. chamelaeagnea constituents on inhibition of Fe2+-induced microsomal 
lipid peroxidation. 
*Data are expressed as IC50 with isolated compounds screened at 100 μg/mL 
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Six known compounds were tested for total antioxidant activity, most of them have been shown 
to possess antioxidant activity and have been implicated as inhibitors of lipid peroxidation. 
Excellent total antioxidant activities were demonstrated by C1, C5 and C2 respectively as FRAP 
(9338.92 ± 1.72; 8622.73 ± 1.92; 4695.98 ± 2.59) µM AAE/g; TEAC (16505 ± 0.86; 10641.5 ± 
0.52; 5897.5 ± 1.03) µM TE/g; ORAC (14550.5 ± 3.65; 14633.90 ± 3.84; 10398 ± 1.81) µM 
TE/g and including the inhibition of Fe2+ -induced lipid peroxidation (IC50 = 32.5; 30.25; 38.35) 
µg/mL, and dedicated them as potent antioxidant agents. It has been reported that the antioxidant 
activity of Salvia and Rosemary is related to the presence of carnosic acid and carnosol, which 
account for approximatively 90 % of the total antioxidant activity of the plant (Kamatou, et al., 
2009). C1, C2 and C5 have been reported to exhibit remarkably strong antioxidant activity 
(Miura, et al., 2002), which corroborate with our findings. C2 has been reported to have strong 
antioxidant activity with TEAC value of (5600.0 ± 1.0 µM TE/g) (Erkan, et al., 2008) and 
ORAC (6489 µM TE/g)(Ibarra, et al., 2010), which is due to the presence of the ortho-dihydroxy 
group in the C ring (Miura, et al., 2002). These findings are in agreement with our result with 
TEAC (5897.5 ± 1.03 µM TE/g) and ORAC (10398 ± 1.81) µM TE/g). C1has been reported to 
be the most potent antioxidant phenolic diterpenoid of Lamiaceae such sage (Masuda, et al., 
2005). It can be confirmed by the result obtained during our research where C1 demonstrated the 
highest antioxidant activity on TEAC and FRAP due to its higher capacity of transferring 
electron to the corresponding cationic radical, while C5 demonstrated the potent antioxidant 
activity on ORAC and LPO. This is the first report on the total antioxidant activity of the isolated 
constituents of S. chamelaeagnea and the obtained result is a good indication for the 
establishment of the relationship between the chemical structure and the antioxidant activity of 
the compounds in term of electron transfer or hydrogen transfer agents. 
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CHAPTER 5: CONCLUSION AND RECOMMENDATIONS 
The aim of this study was directed towards the preliminary screening of twenty five (25) South 
African Lamiaceae for their potency of tyrosinase inhibitory activity using different three 
complementary assays. The outcome of this screening nominated S. chamelaeagnea, the 
bioactive plant materials for chromatographic isolation of such metabolites responsible for the 
biological activity demonstrated at the preliminary stage. The extraction procedure of the 25 
plant materials were successfully carried out using methanol, after which the methanol extracts 
were filtered and concentrated under vacuum.  
The preliminary phytochemical screening using solvent system DCM: MeOH (97:3) on TLC 
showed S. chameleagnea to possess variety of class of compounds varying from terpenoids, 
flavonoids, and other phenolic compounds (Kamatou, et al., 2007). 
The preliminary biological screening of the plant extracts against tyrosinase indicated Salvia 
chamelaeagnea, Salvia dolomitica, Plectranthus ecklonii, Plectranthus namaensis, and 
Plectranthus zuluensis, with significant zone of inhibition against tyrosinase on TLC bio-
autography, spectrophotometry result showed that extracts of Plectranthus zuluensis (IC50 = 
23.99 𝜇g/mL), P. ecklonii (IC50 = 21.58 𝜇g/mL), Thorncroftia succulent (IC50 = 36.08 𝜇g/mL), 
and P.  madagascariensis (IC50  = 23.99  𝜇g/mL) demonstrated good anti-tyrosinase activity 
when compared with kojic acid (IC50 = 3.607 μg/mL). On the other hand, cyclic voltammetry 
indicated kojic acid as the strongest tyrosinase inhibitory activity by decreasing the inhibition 
current with time, followed by the extracts of P. madagascariensis, P. zuluensis, S. 
chamelaeagnea and S. dolomitica. Some level of agreement between these assays was therefore 
observed and considered significant. 
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Phytochemical investigation carried out on the bioactive extract of Salvia chamelaeagnea using 
different chromatographic methods including column chromatographic and semi preparative 
HPLC afforded six (6) known compounds identified as carsonol (C1), carnosic acid (C2), 7- 
ethoxylrosmanol (C3), ursolic acid (C4), rosmanol (C5) and ladanein (C6). Their chemical 
structures were fully elucidated by analyses of spectroscopic (1H and 13C NMR) data as well as 
correlations with existing literature. These compounds are listed as follows (Table 5.1): 
Table 5.1: List of the isolated compounds from S. chamelaeagnea 
Code Name and chemical structure 
C1 OH
O
O
HO
 
Carnosol 
C2 OH
HO
HOOC
 
Carnosic acid 
C3 
 
OH
HO
O
OC2H5
O
 
7- ethoxy-rosmanol 
 
C4 
 
 
 
 
 
 
 
 
Ursolic acid 
COOH
HO
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C5 OHOH
O
OH
O
 
Rosmanol 
C6 
O
OH
HO
MeO
OMe
O  
Ladanein 
 
The methanolic extract of S. chamelaeagnea (SC) showed moderate anti-tyrosinase (IC50 = 267.4 
µg/mL) activity, while the total antioxidant activities measured as: Oxygen radicals absorbance 
capacity (ORAC; 14970 ± 5.16 µM TE/g), ferric-ion reducing antioxidant power (FRAP; 
9869.43 ± 7.87 µM AAE/g) and trolox equivalent absorbance capacity (TEAC; 13706.5 ± 0.95 
µM TE/g). Excellent total antioxidant capacities were demonstrated by C1 and C5 respectively 
as FRAP (9338.92 ± 1.72; 8622.73 ± 1.92) µM AAE/g; TEAC (16505 ± 0.86; 10641.5 ± 0.52) 
µM TE/g; ORAC (14550.5 ± 3.65; 14633.90 ± 3.84) µM TE/g and inhibition of Fe2+-induced 
lipid peroxidation (IC50 = 32.5; 30.25) µg/mL. All the compounds except C4 are electro-active 
with well-defined oxidation-reduction peaks while C1 demonstrated the highest tyrosinase 
inhibitory activity by strongly decreased the inhibition current with time using cyclic 
voltammetry method.  
Based on the findings of this study, the prerequisite for strong antioxidant activity assessed in 
these assays was the presence of an ortho dihydroxy group on the C-ring, which may be valuable 
as a potential antioxidant and lipid peroxidation preventer (Miura, et al., 2002). The total 
antioxidant capacities demonstrated can be considered as significant information which can be 
used as a guide for further studies. 
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From the above, it is recommended that 
 Further studies on this plant should be carried out to investigate the compound(s) 
responsible for the tyrosinase inhibitory activity demonstrated by the extract S. 
chamelaeagnea. 
 Further improvement is required in the electrochemical method as a new method for 
detection of tyrosinase inhibitors. 
 Applications of these chemical constituents in cosmetic, pharmaceutical and food 
industry will require proof of its antioxidant and skin-enzyme inhibitory effects in an in 
vivo model. Further analyses such as cytotoxicity and effects of the compounds on 
melanoma cells, carcinogenic and mutagenic effect, as well as clinical trials are 
recommended in the purpose of translation the current findings into final cosmetic, 
pharmaceutical and food product formulations.  
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